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Clean Air Systems and the Operating Room
Where do 
the pathogens 
come from?
ohn Chamley, the orthopedic surgeon who 
pioneered clean air systems in the operating 
x>m, reduced post-operative infection rates 
fter total hip procedures by a factor of seven 
uring the nine year development of his now 
imous “Greenhouse.” He could have rested on 
lis accomplishment, but instead he pursued the 
tubbom 1.3% infection rate that persisted and 
y 1970 reduced it to 0.34%. His work uncovered 
lany subtleties of infection by airborne patho- 
ens in the surgical environment.
"he Chamley Greenhouse, isolating the operat- 
lg team from the outer theatre by transparent 
/alls and supplied with its own filtered air, pro- 
ided a dramatic reduction of the post-operative 
flection rate early in Mr. Chamley’s program 
1959 to 1962). From the beginning, however, he 
oncemed himself also with bacteria generated 
iside the enclosure. Most obviously these 
riginate from expired droplet nuclei and parti- 
les dislodged from exposed skin and hair:
4r. Chamley’s gowning disciplines were strict, 
saving only the eyes exposed.
T ess obvious was the possibility that epithelial 
I j  scales could migrate from the body surface 
through the clothing, but Mr. Charnley conducted 
tests which confirmed this source of bacteria 
and specified cotton fabrics of special weave to 
resist it. Further, he devised vacuum body 
exhaust systems for each member of the team to 
draw off both epithelial scales and expired 
droplet nuclei.
The most recent improvement in post-operative 
infection rate (1.3% to 0.34% from 1969 to 1970 
—a four times reduction) is attributed by 
Mr. Chamley tentatively to improved prevention 
of scale migration through the textile of the gown.
Unless controlled, airborne pathogens can travel to the wound site not only from the 
operating team, but from the air outside the 
central zone and from unclean surfaces within 
the zone. Enclosing walls are effective in prevent­
ing the intrusion of particles, yet even they may 
present a hazard if they accumulate dust on their 
inner surfaces by electrostatic attraction, as 
acrylic plastic tends to do. Glass is the preferred 
material. The floor also stores contaminants, thus 
a positive downward airflow is desirable to 
prevent infectious dust from being swept up 
into the wound.
) 1972Codbnan & Shurtleff, Inc. ^Trademark
T T o w  do these criteria apply to a clean air system 
J- X  that has an enclosing air curtain instead of 
solid walls? The pathogens originate from the 
same sources, but the hazards are reduced by the 
geometry of the air flow. The Allander* “Air 
Curtain, in use at over 100 hospital installations 
isolates the operating site from the outer theatre ’ 
by a four-sided high-velocity stream of filtered 
air which entrains impinging particles downward 
and outward. Inside the air curtain, a separate 
supply of filtered air pushes downward and 
away from the wound site carrying droplet nuclei 
and epithelial scales into the entraining air 
curtain. Contamination from the outer theatre is 
likewise carried by the curtain air to exhaust 
vents m the walls of the room. Since there are no 
walls, there is no threat of dust accumulation 
there. Particles cannot rise from the floor due to 
the positive downward pressure.
^ ^o d m an  s O.R. Systems Division recom- 
V -' mends the only two clean air systems with 
a substantial record of medico/engineering 
results in surgical environments: the original 
Chamley Greenhouse and the Allander Air 
Curtain. Our exclusive representation of these 
systems m the U.S. includes engineering plan­
ning, installation assistance, and service. Your 
inquiry will bring detailed information and assist­
ance m evaluating the proper choice of clean
° ' R' Systems Division, Codman& 
bhurtleff, Inc., Randolph, Mass. 02368.
Codman
O.R. Systems Division
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QUILL ON SCALPEL This section 
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
C. J. S. —  ITS SIGNIFICANCE FOR 
TOMORROW
As the decade of the seventies moves 
i inexorably forward, there is increasing 
evidence that the practice of medicine 
and surgery will undergo many realign­
ments between men and institutions 
and between institutions and govern­
ment. It is in this setting of change that 
the nature of medical journals and the 
many purposes o f publication must be 
viewed, with particular reference to the 
sphere of interest and purposes o f the 
Canadian Jouvnal of Surgery.
In its July issue the Canadian Jour­
nal of Surgery contained editorial com­
ments by Dr. MacLean1 reappraising 
the status of the Journal, outlining 
some of today’s fiscal and adminis­
trative problems, reviewing its format, 
describing a desired liaison with some 
of the Canadian surgical societies and 
pledging continued effort on the part 
of the Co-editors to enhance the distin­
guished career of the C.J.S. during the 
coming years.
Although intense preoccupation with 
surgical research has dominated the 
efforts of many surgical centres in the 
past years, it now appears that the 
promise of tomorrow will intertwine 
research effort with concerns related to 
the delivery of surgical care and to in­
creasing accountability to the public on 
the part of our profession. Medical jour­
nals generally, and the Canadian Jour­
nal of Surgery specifically, will thus 
provide a forum where such concerns 
can receive attention and where the 
many problems of health-care delivery 
and health-manpower production may 
be discussed by all the surgeons of Can­
ada. Publication o f results of treatment, 
a sharing of new and old surgical ideas, 
the introduction o f innovative methods 
in general patient management (not 
only in surgical operative techniques), 
thus attain increasing significance, for 
these elements will serve as a standard 
o f reference for all Canadian surgeons. 
Against this standard the quality of 
care, efficiency o f management and 
analysis o f therapeutic outcome may be 
measured.
It is appropriate at this time to ask 
again the question, “ Why publish?”  Is 
this only a problem for academics, 
phrased as “ publish or perish”  or does 
it have a place in the life of the up-to- 
date surgeon? In answering this last 
question in the affirmative, we would 
remember that publication carries dual 
benefits— some for the author and some 
for the reader and, as well, imposes on 
editors the obligations of ensuring that 
what is published is relevant, appro­
priate and current.
For the author, publication enables 
him to review his experiences and those 
of his colleagues, to evaluate critically 
the management o f  his cases and to 
describe the outcome achieved in his 
patients. It provides an opportunity to 
propose novel methods and to publicize 
innovative ideas with the knowledge 
that scrutiny by an editorial board will 
attempt to ensure quality of perform ­
ance, accuracy of reporting and validity 
of results. Thus the editorial discipline 
required o f an author and the critical 
approach needed to review surgical 
practice or present new ideas serve the 
author as a “ mini” medical audit o f his 
own practice or an audit of activities 
within his institution.
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For the reader, in addition to provid­
ing standards of reference, medical pub­
lications have become the means of con­
tinuing education. They give a reader 
a means of assessing changing stand­
ards of practice, changing methods of 
treatment, changing concepts under­
lying the surgical effort, and the stim­
ulus to explore new approaches to the­
rapy and derive new concepts of di­
sease. Sharing the role of verbal presen­
tation at meetings, medical journals 
stand as the centerpiece of the continu­
ing educational effort. It is this obliga­
tion of publication which creates an 
overriding imperative for the Journal 
and which dictates the editorial format 
of the Canadian Journal of Surgery.
Your editors and your editorial board 
have pledged themselves to provide a 
journal which fulfils the needs of con­
tinuing education by “ audience parti­
cipation” in the editorial pages and 
which encourages further development, 
expansion or exchange of ideas regard­
ing the conduct and the context of sur­
gical practice. During the past several 
years review articles have attempted to 
provide a continuous updating of the 
current thought in frontier areas of 
research and in new scientific develop­
ments which seem of importance to sur­
geons. Pertinent research has been pub­
lished as submitted, partly for the bene­
fit of other workers in the same field 
and partly to keep our readers aware 
of efforts which may presage new 
ideas and new thoughts that are apt to 
impinge upon and modify the changing 
scene of surgical practice.
Thus, your Co-editors propose to seek 
connection with and sponsorship by 
Canadian surgical societies, a speedy 
publication of manuscripts, a readership 
composed of all Canadian surgeons and 
provide a forum for Canadian surgical 
ideas. We recognize a continuing obliga­
tion to provide a central resource for 
continuing education, to permit the de­
scription of innovative surgical prac­
tice and to present new research ideas. 
This is our goal and, if achieved, the 
Canadian Journal of Surgery can in­
creasingly become a forum where Cana­
dian surgeons may discuss their areas 
of interest, share ideas and present the 
best outcomes of current surgical effort.
C. Barber M ueller
Reference
1. MacLean LD: C.J.S.— reappraisal (edi­
torial). Can J Surg 15: 213, 1972
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CAMPBELL B. KEENAN, D.S.O., M.D., C.M., F.R.C.S.rCl
1867 TO 1953
D. SCLATER LEW IS, M.D.,* Montreal, Que.
Ca m p b e l l  K e e n a n  was one of the most 
engaging characters on the staff of the 
Royal Victoria Hospital, Montreal, at 
the end of the First World War. One 
of the senior surgeons, he had a consi­
derable practice and was widely con­
sulted by doctors of Italian and other 
ethnic groups in the city. To the his­
torically minded he was a man of mys­
tery; there were two subjects about 
which he never spoke— his age and his 
family background. In a general way he 
was thought to be of Irish extraction 
and to have come from the Ottawa 
neighbourhood.
He was a tall athletic person with 
strong rather than handsome features, 
a brusque manner, fond of argument 
and rather against the Establishment 
(Fig. 1). He was a great lover of horses 
and animals, a good rider, a member of 
the Montreal Hunt and the Montreal 
Jockey Clubs. Unlike Dr. Edward Ar­
chibald, he had no interest in research, 
and in later life he told one of his assist­
ants, Dr. Mason Couper, that it was his 
love of animals that had prevented him 
from ever doing any experimental or 
surgical research.
Keenan’s great interest at the time 
and indeed all through his life was the 
army and its veterans. While he had 
been a member of the Hospital staff 
since 1897, this was interrupted by five 
years of war service. In 1899 he enlisted 
in the Strathcona Horse as its medical 
officer with the rank of Captain, and 
after 18 months’ service in South 
Africa he returned to Canada with the 
Distinguished Service Order. For the 
rest of his life, no matter what his ac­
tual rank might be, his nickname among 
his friends was always “Cap” Keenan. 
Immediately after the outbreak of the
*31 Ramezay Road, Westmount, Montreal 217, 
Que.
j
„  L —Graduation photograph as M.D.,
C.M. m 1897 at McGill University (Notman 
Collection).
First World War, he joined the Prin­
cess Patricia’s Canadian Light Infantry 
as its medical officer with the rank of 
Major. This regiment had been or­
ganized by Hamilton Gault of Montreal 
and there were many British reservists 
in its ranks. It went overseas before the 
First Canadian Division; it was sent to 
France in December 1914 where it was 
attached to the British army. The regi­
ment went through all the heavy fight­
ing of the following spring and by the 
end of the Second Battle o f Ypres, in 
June 1915, casualties had reduced its 
strength to five officers and 150 men. 
The regiment was then withdrawn from 
the forward area for reorganization. 
The regimental history gives the fol­
lowing note on the value of Dr. Kee­
nan’s services: “ Major C. B. Keenan, 
the distinguished M.O. of ‘The Origin-
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Fig. 2.—A snapshot probably taken in France 
after the Second Battle of Ypres.
als’ was transferred to an important 
hospital at Le Treport where he later 
became the C.O.* His loss was keenly 
felt for by virtue of his personality and 
his soldierly qualities he had been one 
of the ‘Master Builders’ of the regi­
ment.” 1 (Fig. 2).
He returned to Canada in 1917 be­
cause of the acute shortage of surgeons 
at the teaching hospitals at McGill Uni­
versity and took charge of the military 
wards at the Royal Victoria and Grey 
Nuns’ Hospitals. He remained in active 
contact with the medical care of the 
veterans until the second year of World 
War II when he finally retired from the 
army.
To return to the Keenan biography, 
the two mysteries—his age and his fam­
ily background— were still unsolved. 
Books of reference gave widely varying 
dates of birth: 1868, 1870, 1872 and
*No. 2 Canadian General Hospital. He was 
Officer-in-Charge of Surgery with the rank 
of Lieutenant-Colonel.
even 1876. The true date was settled by 
his death notice in 1953 when he was 
stated to have been in his eighty-seventh 
year, making 1867 his date of birth. 
This discovery aroused some amuse­
ment among the older members of the 
Hospital staff because when he resigned 
voluntarily in 1935 he was at least five 
years beyond the official retirement age 
of both the Hospital and the University. 
His secrecy had paid off.
His family background and early life 
still remained a mystery. Campbell 
Keenan had kept very few of his per­
sonal records and, in 1964 ,when I was 
gathering materials for biographic 
sketches of the early members of the 
Royal Victoria Hospital staff for the 
hospital history, the only things his 
family could send me were a short note 
about his society memberships and a 
tattered group of pages loosely sewn 
together in a manila paper cover, bear­
ing the title “ Dr. C. B. Keenan’s Ar­
ticles in the Medical Times of 1844 on 
Liebig’s Theories” . There were also a 
number of newspaper clippings refer­
ring to a series of lectures that a Dr. 
Keenan had delivered in the Town Hall 
at Brighton, England, in the same year. 
“ Liebig” proved to be Professor Liebig 
of Giessen, Germany, who is now re­
garded as one of the fathers of organic 
chemistry. His mechanistic theories, that 
all physiologic processes were chemical 
reactions which could be repeated in the 
laboratory without any contact with 
living matter, had aroused a controver­
sy with the “ vitalists” almost as violent 
as that which attended the announce­
ment of Darwin’s “Origin of Species” 
some 10 years later. The Dr. C. B. Kee­
nan of 1844 had set himself up as one 
of Liebig’s critics, and his approach to 
the question was so like the mental 
processes of our own Campbell Keenan 
that the two men must have been closely 
related. Efforts to establish this rela­
tionship led to the discovery of our own 
Campbell Keenan’s family history 
which goes back in a direct line for five 
generations (Fig. 3). As a bonus, we 
now have a description of the Bell’s
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Edward K eenan  m. E l iz a b e th
of Aberdeen, Scotland. Went to Ireland 
(3 sons)
James Keenan m. Mary Agnew 
(7 sons and 1 daughter)
John m. Nancy McKechnie 
(10 children)
To Canada 1828
IThomas m . *
David Campbell Keenarvf 
* Mrs. Thomas Keenan, the compiler of the Family Tree.
James
K i l le d  i n  a c t i o n  i n  S pa in
Andrew
Army su rg e o n , S p a in  and Canada D ied i n  t r o p ic s
C am pbell B .,  M.D. m. J a n e  
McMurtry Canada in 1846 
(3 sons and 1 daughter)
David Keenan m. Robina 
Smith or Maxwell (3 sons)
Dr. C .B. K eenan (M o n tre a l)
+ Mr. D avid C am pbell K eenan , O ttaw a, r e t i r e d  f a rm e r .  D ied May 1 5 , 1971.
Fig. 3.—The Keenan fam ily tree.
Corners District School where his father was the teacher and at which he received his own primary education before going on to the Ottawa Collegiate Institute for his high school studies. The results of these inquiries are de­scribed in greater detail in the second part of this article (pages 292 and 293).After graduation from the Collegiate Institute, our Campbell Keenan taught at a village school, similar to the one at Bell’s Corners, for five or six years. The school house is still standing near the entrance to the Connaught Rifle Ranges but has been converted to a private dwelling. He went to McGill in 1893 and graduated in 1897 with his medical de­gree, and a very distinguished scholastic record. He was the second-year prize­man in the Preliminary Subjects, he won the Sutherland Gold Medal in Chemistry, and was the third man in the final year, winning the prize in sur­gery—a two-volume edition of “A Manual of Operative Surgery” by Sir Frederic Treves.
Following graduation he was ap­pointed to the Royal Victoria Hospital house staff on Dr. James Bell’s service. Even at that time Bell had established a four-year system of postgraduate train­ing consisting of a year in surgical pathology, two years as intern on the wards, and a final year as resident with increasing responsibility as time went on. Keenan had spent the first year in
surgical pathology and a further 11/2 years on the wards and then, as noted above, he resigned to join the Strath- cona Horse. On his return to Can­ada, he was appointed to the attending staff as a clinical assistant in surgery.In an address, which appeared in the 
Montreal Medical Journal in 1902,2 Keenan described his experiences in South Africa under the title “Notes of a Regimental Medical Officer in a Mounted Infantry Corps”. His chief at­tention was directed to the ravages due to enteric (typhoid) fever and he made little reference to military action. In his address he mentioned that he had met a McGill classmate, Dr. Charles A. Pe­ters, who was on the staff of a British fever hospital in South Africa. The 
Strathcona Horse had gone directly from Canada and had not been given the new vaccine. On the other hand Peters had joined up in London, and he often spoke in later life of having been inoculated by Sir Almroth Wright, the inventor of the vaccine, while on the transport going to Capetown. The stan­dardization and dosage of the vaccine were still in the experimental stage and some of the reactions were terrific. However, Peters never had an attack of enteric fever during the time he was in South Africa. Keenan’s interest in animals also comes out; for example, he notes the superior qualities of the ori­ginal horses, which had come from
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Western Canada, over those supplied by 
the British remount depots. There is 
also an amusing story about his ability 
as a mule trader and his success in im­
proving the quality of the mules in the 
regimental ambulance service. The 
Strathcona Horse was unusual in other 
ways: lassos were standard equipment 
for the rank and file. Finally he deals 
with the selection of men for army 
service. In his opinion, large well­
muscled men had their defects— their 
attacks of illness were more severe and 
so were their wounds. Men of average 
size and the smaller ones were much 
tougher. The highly optimistic were 
poorer psychologic risks than the pes­
simistic; the optimists took disappoint­
ments badly, the pessimist felt he al­
ways knew that things would go wrong 
and was a little proud that he had been 
right from the beginning. I was in­
terested to hear in a recent address on 
the choice of men for service in the Far 
North that Dr. Keenan’s criteria are 
still on the modern list of desirable 
qualities.
In 1904 he was appointed Assistant 
Surgeon of the Royal Victoria Hospital 
in charge of the outpatient department. 
He had ward privileges only when the 
senior members of the staff were out of 
town, but this restriction was soon re­
moved. However, there were very few 
private rooms and like many of the 
junior surgeons of the early 1900’s his 
private work was done largely at the old 
Homeopathic Hospital on McGill Col­
lege Avenue. James Bell, A. E. Garrow 
and, later, George Armstrong monopol­
ized the private wards at the Royal Vic­
toria Hospital.
Dr. Keenan married Miss Winifred 
Hagar in 1905 and transferred his of­
fices to Mountain Street, at that time 
the Harley Street of Montreal. They 
were both lovers of horses and animals 
and, for some years, were active mem­
bers of the Society for the Prevention 
of Cruelty to Animals. Promotion at the 
Hospital came slowly after the un­
expected death of his old chief, Dr. 
James Bell, in 1911. He was one of the
first to go overseas after the outbreak 
of war in 1914 and, after his return in 
1917, he was so involved in his military 
duties that he almost disappeared from 
the hospital scene and it was only after 
the sudden death of Dr. Harry Hill and 
the approaching retirement of George 
Armstrong, in 1922, that he was ap­
pointed to the rank of full surgeon with 
a ward service of his own.
When Sir Henry Gray took over as 
Surgeon-in-Chief in September 1923, 
Dr. A. E. Garrow was seriously ill and 
died the following November. For years 
Garrow had had the largest surgical 
service in the Hospital; Sir Henry took 
charge of his beds in the public wards 
and he did not disturb the other serv­
ices. When he left the Hospital two 
years later, Dr. Edward Archibald and 
Dr. Keenan were appointed Senior Sur­
geons and divided the surgical beds be­
tween them. Drs. F. A. C. Scrimger 
and F. E. McKenty were their respect­
ive assistants. (Scrimger had won the 
Victoria Cross at the Second Battle of 
Ypres, and both he and McKenty would 
later be Surgeon-in-Chief of the Hospi­
tal.) Archibald was appointed Surgeon- 
in-Chief in 1928 but the equal division 
of the surgical beds was maintained 
until they both retired from the active 
staff at the end of 1935.
Throughout his active life, Keenan 
remained a general surgeon, a good 
diagnostician, conservative in outlook, 
and a rapid and skilful operator. He 
knew when “ to go in” and when “to get 
out” and, as a result, he had few post­
operative infections and complications. 
He liked to know what he was doing. 
For example, as a railway surgeon he 
did a great deal of fracture work and, 
when Arbuthnot Lane introduced bone 
plating in the management of fractures, 
he spent some time at the Lane Clinic 
in England before using the method 
himself. According to one of his old in­
terns, the late Dr. A. D. Campbell, his 
results were excellent.
The didactic lectures of the day were 
not in his field but it was a different 
matter in the wards. He was a great
September 1972 CAMPBELL BROWN KEENAN 291
reader, well informed, dogmatic and al­
ways ready for an argument; all these 
qualities had a strong appeal for his 
students and interns. He was a good 
teacher and was really at his best in the 
wards and the outpatient department. 
He was one of those who believed that a 
good history was half the battle in ar­
riving at a correct diagnosis. In the ear­
ly days there were a great many Italian 
immigrants in the “ Out Door” . Mrs. 
F. A. C. Scrimger who still has the gift 
of languages (Italian, French and Ger­
man) recalls that when she was a stu­
dent nurse she would often be sent to 
the “Out Door” to act as an interpreter. 
In most cases she would find that it was 
an old confused Italian patient of Dr. 
Keenan’s who understood no English. 
Despite this, the doctor would take end­
less trouble to get a clear history.
In spite of his brusque manner, Kee­
nan was always popular with the nurs­
ing staff. He was a minor hero at the 
time of his return from the South 
African war in 1901. His love of horses 
was well known and the story went 
round the Hospital that he and his horse 
had served as the models for the eques­
trian statuary on the Strathcona Horse 
monument which had just been erected 
in Montreal. The story later proved to 
be apochryphal but was widely accepted 
by the nurses. He was always a sup­
porter of the weak against the strong, 
especially when the Establishment was 
concerned. One of the nurses who later 
became the secretary of the Nurses’ 
Alumnae Association told me about her 
own experience with Dr. Keenan when, 
as an undergraduate, she was taking 
her first turn as instrument nurse at 
one of his operations. The head of the 
operating-room staff was a real tyrant 
and kept coming into the room and 
pointing out her errors in technique, 
real or imagined. Finally Dr. Keenan 
looked up and said, “ Will you please 
get out of the room and give the girl 
a chance.” The nurse said that she 
would never forget her feeling of relief 
and self-confidence which followed Dr. 
Keenan’s outburst.
His private patients were extremely 
loyal to him. I well remember my sur­
prise in 1914 when I heard that Dr. 
C. F. Martin had recommended Keenan 
to Sir Thomas Shaughnessy as the sur­
gical consultant for one of his family. In 
doing this he had passed over two of 
the senior surgeons of the Hospital. I 
left the Hospital shortly afterwards and 
did not hear anything more about the 
operation, but the results must have 
been very satisfactory indeed. In a pro­
file of Lord Shaugnessy which appeared 
in The Gazette (Montreal) on February 
20, 1971, E. A. Collard noted that Dr. 
David Gurd (the family physician) and 
Drs. C. F. Martin and C. B. Keenan had 
been called to attend Lord Shaughnessy 
during his last illness in December 
1923.3 Dr. Keenan apparently still held 
his place as surgical adviser and friend 
of the family some nine years later.
Keenan was an inveterate cigarette 
smoker and, when absorbed in anything, 
rarely thought of an ash tray; as a re­
sult, the ashes often fell on his clothes. 
Stories came back from No. 2 Canadian 
General Hospital at Le Treport that he 
had been known to operate with a ciga­
rette in his mouth. Fortunately chloro­
form was the anesthetic of choice in the 
British army and as it was not flam­
mable no harm came of this habit. How­
ever, his smoking aroused some concern 
when he returned to Canada in 1917 
where ether and explosive gases were in 
common use. It was before the introduc­
tion of surgeons’ masks and he would 
commence washing up while he was 
smoking and would start for the oper­
ating room with the lighted cigarette 
still in his mouth. A nurse was always 
stationed at the door of the theatre to 
make sure that he had remembered to 
discard the cigarette. The introduction 
of surgeons masks shortly afterwards 
made these precautions unnecessary.
Dr. Keenan retired from practice in 
1941 and went to Bic, a village on the 
Lower St. Lawrence River about 300 
miles below Montreal. Here he lived in 
a house thought to have been a Hudson’s 
Bay trading post which had been in the
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possession of his wife’s family, the 
Hagars, for many years. The Hagars 
had always been collectors of things of 
historic interest and the house was a 
veritable museum of old French Cana­
dian furniture which they had collected 
over many years. Here Dr. Keenan had 
his own collection of army weapons— 
muskets, rifles and pistols and swords— 
of which he was very proud. He died in 
1953, his wife having predeceased him 
in 1949. They had no children.
T he K ee n a n  Fam ily  Tree (Fig. 3)
As noted earlier, our Campbell Kee­
nan had not been greatly interested in 
family history and had left little infor­
mation about his immediate family ex­
cept the tattered packet of pages re­
moved from the May to November num­
bers of the Medical Times of 1844. The 
Medical Times, a well-known London 
journal, was published from 1839 to 
1887. The full title of the articles was 
“ The Truths and Falsehoods of the Lie­
big Theories With New Views on Some 
Important Points of Organic Chemistry 
and Physiology” . The articles had 
aroused some interest because the writ­
er was asked to give three lectures on 
the subject in the Town Hall at Brigh­
ton, England, in the following autumn. 
C. B. Keenan apparently was a good 
speaker because newspaper clippings 
pasted on the cover state that the lec­
tures were delivered before large and 
respectable audiences with a sprinkling 
of medical gentlemen whose interest 
was held throughout. A final proof is 
that the articles drew a counterblast 
from Liebig’s own laboratory in Gies­
sen.
One of his articles emphasized the 
importance of electricity in the actual 
transmission of nervous impulses over 
the sensory and motor nerves and sug­
gested that this electricity might be 
produced by chemical reactions in the 
body. However, in Keenan’s opinion 
chemical reactions were much too slow 
to explain the instantaneous sense of 
pleasure on kissing a good-looking 
woman. Other more intimate situations
are described in the article, but there 
are marginal notes that these were not 
suitable for a mixed audience.
The whole approach to the subject 
and the love of argument was so like 
our own Dr. Keenan that it became im­
portant to identify the author. Was it 
his grandfather or an uncle or a distant 
relative? In 1964, one of my classmates, 
Dr. H. T. Douglas, made a search of 
early Ottawa directories and found that 
the Keenan family held farm property 
in the Bell’s Corners area but that the 
school teacher had been David Keenan 
and not C. E. Keenan as given by Kee­
nan’s nephew. Dr. Douglas suggested 
that I write Miss Evelyn M. Taylor, a 
director and the Secretary of the Carle- 
ton-West Russell Historical Society. I 
did and her reply brought a regular 
mine of information. She had found 
one of the few survivors of the original 
Keenan family, Mr. David Campbell 
Keenan, a retired farmer, then in his 
eighties but “ as bright as a dollar” . He 
had allowed her to send me a copy of a 
well-worn paper which had been found 
in a biscuit jar in his mother’s kitchen 
after her death at the age of 90. It was 
a “ family tree” of the Keenan family 
going back for five generations. It set­
tled many of our problems.4
The founder of the Ottawa branch of 
the family was Edward Keenan, a Scot­
tish Presbyterian from Aberdeen, Scot­
land, who had gone to Ireland with his 
wife and settled in County Antrim, five 
miles from Belfast. This would have 
been in the early 1700’s. There were 
three sons in the second generation. The 
eldest son, James, married Mary 
Agnew, an Englishwoman, and they had 
seven sons and one daughter. The 
daughter married a shipwright, went to 
Nova Scotia, and was lost to view. The 
second son of the third generation, John 
Keenan, married Nancy McKechnie and 
they had 10 children; one, an infant, 
died on the voyage to Canada, but seven 
others were born in the Bytown (Otta­
wa) area. The family arrived in 1828 
two years after the Rideau canal system 
was begun. At that time Bytown was a
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collection of log cabins. Miss Taylor’s 
informant, David C. Keenan was a 
member of this branch of the family.
The third and fourth sons of this 
generation, James and Andrew, were 
twins and they had joined the army and 
served in the Peninsular War under 
Wellington. James was killed in action 
in Spain but Andrew was an army sur­
geon and later came to Canada. His re­
giment was stationed in Montreal but 
he appears to have visited the Bytown 
area “before a tree was cut” . He later 
was transferred to the tropics where 
he died from a snake bite.
Dr. C. B. Keenan was the sixth son of 
this generation and was the writer of 
the Liebig articles. He married Jane 
McMurtry and they had three sons and 
one daughter, Annie. The old paper had 
a note that his wife was a sickly person 
who lay in bed for 17 years after the 
birth of her family. The family came to 
Canada in 1846 and the doctor practised 
at Huntley, a village about five miles 
from Bell’s Corners. Annie did not come 
to Canada with the family. She was left 
in the care of one of the doctor’s London 
patients, a very rich French lady with 
whom she lived until her death 16 years 
later.
David Keenan was their eldest son, a 
member of the fourth generation and 
the father of our own Campbell Kee­
nan, and for some years he was the vil­
lage school teacher at Bell’s Corners. 
The school house and the teacher are 
described in the Ottawa Citizen, Decem­
ber 12, 1925, in an article by William 
Arnold, one of David Keenan’s old pu­
pils.5
The school was a one-room frame 
building with about 60 scholars ranging 
from 6 to 20 years of age. The older 
scholars had never attended school and 
were learning to read and write. They 
sat on benches facing the wall, the desk 
being a sloping shelf along the side of 
the room. Heating was provided by a 
large wood-burning box stove in the 
centre and at the end of the room sat 
the “ one and only teacher” . As each 
group finished its work, it was called
to the open space between the stove and 
the teacher’s desk “ to be heard their 
lessons” , during which they always re­
mained standing.
Arnold described David Keenan as a 
fine-looking young man of 20 or 25 
years, one of the best of the early Carle- 
ton County teachers of his day. Letters 
in the archives of the historical society 
note that he was a widely read man and 
a good conversationalist. However, the 
family thought him “ a dreamer of 
things to come” based on his habit of 
calling the school together for the last 
class of the week when he would speak 
of great inventions to come. Like his 
father, electricity was one of his favour­
ite subjects and he spoke of the day 
when it would be produced in large 
power-houses and replace steam in fac­
tories and workshops.
David Keenan died in Ottawa in the 
early 1920’s and, according to Miss Tay­
lor, Keenan Street in western Ottawa 
was named in his honour.
None of the men of the Keenan fam­
ily ever showed any interest in making 
notes about the family history and it 
remained for, as the Scots say, one “ not 
of the blood” , in short a wife, to put to­
gether the old stories about the Keenan 
family. If heredity plays any role in the 
lives of later members of a family, our 
Campbell Keenan’s career might have 
been predicted from his family back­
ground. He came from a branch of the 
family with definite army and medical 
leanings. Two of his grand-uncles had 
been in the Napoleonic wars, one o f 
them was killed in action in Spain 
and the other was an army sur­
geon. Edward Keenan of Aberdeen, the 
founder of the family, might very pos­
sibly have gone to Ireland as a soldier. 
This explains our Keenan’s interest in 
the army and the war veterans.
Again both the grandfather and the 
grand-uncle were medical men and the 
grandfather was the doctor in a nearby 
village. He seems to have been one of 
his grandson’s heroes because the Lie­
big articles were the only family papers 
which were saved by our Dr. Keenan.
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There was little money in the family and it required six years of saving' as a school teacher to allow him to enter Mc­Gill where he was a serious and success­ful student. Like his father, he was a great reader and fond of teaching. He has left behind him a reputation as a brusque but kindly man, a great friend of the poor, a strong believer in the medical profession and a dependable and skilful general surgeon.
The author is indebted to Miss Evelyn M. Taylor of Ottawa for the discovery of the Kee­nan family tree and the article on the Bell’s Corners school; to Miss Patrick, Assistant Reference Librarian, McGill Medical Library,
for information on Dr. Keenan’s writings; to Mrs. Brenda Cornell and to Miss Caron of the Medical Records Department for searches of hospital records; also to Dr. Mason Couper and older members of the staff for personal recollections.
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REVIEW ARTICLE
TISSUE TYPING AND ORGAN TRANSPLANTATION*
D. P. SINGAL, Ph.D., Hamilton, Ont.
T h e  principal obstacle to successful 
clinical transplantation of a human or­
gan is immunologic rejection. The range 
of immunologic response varies from 
complete acceptance of the grafts ex­
changed between identical twins (iso­
grafts) to violent rejection of the grafts 
obtained from other species (xeno­
grafts) . In clinical homotransplanta­
tion, the intensity of the host’s immu­
nologic response to an allograft is 
determined by the degree of genetic 
disparity between donor and recipient. 
Immunosuppressive therapy has been 
remarkably successful in preventing 
immunologic rejection of the kidney 
graft. However, the large doses of- im­
munosuppressive drugs increase the 
risk of complications including bone- 
marrow suppression, a general reduc­
tion of immune responses and the 
adverse side effects of high doses of 
adrenocorticosteroids. Histocompatibil­
ity typing may be used to select op­
timally compatible donor-recipient pairs 
and to decrease the degree of dif­
ferences between the two. Such a 
method would significantly increase the 
long-term survival of the allograft and 
decrease the recipient’s requirements 
for immunosuppressive therapy.
H istocom patibility  A n t ig e n s
Two major antigenic systems, the 
erythrocyte antigens of the ABO system 
and the leukocyte antigens of the HL-A 
system, have been recognized as im­
portant in determining graft rejection 
in humans. The HL-A system is the 
most complex immunogenetic system 
described in man and its antigens are 
determined by genes on a single pair of 
chromosomes (autosomes). The HL-A 
region on each chromosome is divisible
*From the Department of Pathology, McMaster 
University, Hamilton, Ont.
into smaller regions or loci. Two loci 
are at present well defined: the firs t 
(LA) and the second (four or seven).1"1 
To each of the loci belongs a series of 
mutually exclusive alleles, i.e. only one 
allele each is present a t the first and 
the second loci on a chromosome. Thus 
a person has four HL-A alleles (two be­
longing to each locus) which together 
produce his HL-A phenotype. Thus 
there appears to be a close analogy be­
tween the human HL-A system and the 
H-2 antigen system of the mouse.
Fifteen HL-A antigens have been 
given international designations, HL- 
Al, 2, 3, 5, 7, 8, 9, 10, 11, 12, 13, 14, 17, 
27 and 28. In addition, several other 
antigens are currently recognized in 
several laboratories. The first locus in­
cludes the antigenic specificities HL- 
Al, 2, 3, 9, 10, 11, 28 and W29, W30, 
W31 and W32. The second locus in­
cludes HL-A5, 7, 8, 12, 13, 14, 17, 27 
and W5, W10, W15, W16, W17, W21, 
W22 and W27, and probably other spe­
cificities such as SL* and 407*.
T issu e  T y pin g
There are three main methods of tis­
sue (serologic) typing for HL-A anti­
gens: leukocyte agglutination, platelet 
complement fixation, and lymphocyte 
cytotoxicity.
Leukoagglutination test is the sim­
plest method serologically. This test 
involves agglutination of leukocytes, 
particularly granulocytes, by antisera 
containing antibodies to leukocyte anti­
gens—a phenomenon that is influenced 
by many variables such as pH, tempera­
ture, and ion concentration of the test 
medium. Two main methods used are 
the defibrinated blood leukoagglutina­
tion test of Dausset, and the ethylene 
diamine tetra-acetate (EDTA) leukoag­
glutination test of van Loghem. The 
leukoagglutination test has poor repro-
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ducibility and often gives a number of 
false positive and negative reactions. 
However, if carefully performed, this 
method is very useful, since some anti­
gens (e.g. 5a, 5b, and 9a) can only be 
detected by this method.
Platelet complement fixation test was 
discovered while studying platelet anti­
gens, and microtechniques have recently 
been developed in many laboratories.4 
Platelet suspensions are incubated with 
typing antisera and human complement. 
The test is reincubated after adding 
sheep red cells sensitized with rabbit 
anti-sheep hemolysin. The test is read in 
the same way as any routine comple­
ment fixation test.
Lymphocyte cytotoxicity test is the 
method most commonly employed for 
leukocyte grouping. A pure suspension 
of lymphocytes is allowed react with a 
test panel of antisera in the presence of 
complement. If the appropriate anti­
gens are present on the lymphocytes, 
the antibody combines with the antigen 
receptor sites. The antigen-antibody 
complex, thus formed, activates the 
complement components and kills 
the cell. Several recent modifica­
tions of the test concern the method of 
ymphocyte preparation, source of com­
plement used and the manner in which 
cell death is determined. The principal 
advantage of the cytotoxicity test is its 
greater reproducibility. Another advan­
tage is that HL-A typing by lymphocyte 
toxicity can be carried out on referred 
specimens even one to two days after 
withdrawal of blood, therefore permit­
ting cross-testing of blood by several 
laboratories.
Histocompatibility
Considerable evidence indicates that 
HL-A antigens are transplantation anti­
gens.1' Skin grafts in genetically un­
related recipients preimmunized with 
white cells from donors were rejected 
in an accelerated manner." 8 Amos et al. 
and Ceppellini et alP observed that skin 
grafts exchanged between HL-A-iden- 
tical siblings survived significantly
longer than grafts exchanged between 
siblings who shared only one haplotype 
and between siblings different for both 
haplotypes. Few reports have ap­
peared that give information about the 
relative strength of different HL-A an­
tigens. Dausset et al.,11 in skin-grafting 
experiments from siblings to their 
fathers, found that incompatibility for 
HL-A2 and Dal5 seemed to be as­
sociated with a short survival time.
To evaluate the importance of HL-A 
antigens in allograft survival, kidney 
transplant patients are considered in 
three categories, depending upon the 
relationship between donor and reci­
pient: sibling donors (S:S);  parental 
donors (P :C) ;  and unrelated donors 
(UR). In the related-donors series (S:S 
and P:C), we and others have found a 
significant difference in the clinical 
outcome of matched and mismatched 
transplants.12"20 As another measure of 
clinical outcome we investigated the 
effect of leukocyte-antigen compatibil­
ity on the survival of kidney transplants 
by plotting actuarial survival curves. In 
the sibling donors there was a marked 
difference in survival rate between 
matched and mismatched recipients—at 
four years 92% of the matched trans­
plants and only 43% of the mismatched 
transplants had survived.13 Hors et al.20 
reported 100% survival for HL-A-iden- 
tical siblings, a significantly superior 
percentage than the survival rate of 
haplo-identical transplants (P<0.001). 
However, the difference in the survival 
rate was not as marked in parental 
grafts— 81% of matched and 68% of 
mismatched transplants at four years.13 
In a recent report17 no difference was 
observed in the survival rates of 
matched and mismatched P:C trans­
plants at three months, six months, and 
one year after transplantation. Hors 
et al.“  reported a better prognosis for 
more compatible P:C grafts, although 
it was still not statistically significant.
A difference of opinion exists re­
garding the value of tissue typing in 
cadaver-donor grafts. Van Rood,12 Bat­
chelor and Joysey,21 Morris, Ting
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and Forbes,22 Perkins et al,,23 Kiss- meyer-Nielsen et al.,'B and Hors et al.,20 achieved better results when the cadav­er donors were well-matched for HL-A antigens. Hamburger et al,,24 Starzl et al.,25 and Mickey et al.,1B however, found no correlation between HL-A matching and clinical outcome except when donor and recipient have identical HL-A antigens. Harris et a l26 have criticized Mickey’s data on two princi­pal grounds: first, the data are clinical­ly heterogeneous because they were col­lected from more than 50 centres, each centre using different drugs to control rejection; and second, the tissue typing of cadaver blood samples sent from distant centres could have been faulty. These objections could be important, especially in view of the fact that the data from individual centres, although small, show significant correlation be­tween compatibility for HL-A antigens and the prognosis of the renal allograft. In a recent report, Terasaki and Mic­key19 reanalyzed their data from 188 cadaver transplants tissue typed and transplanted between January 1969 and October 1970. A superior outcome of A (identical) match over incompatible matches was evident (P = .006).
Com m ents
Attention is now being focused on the role of leukocyte antigens in organ transplantation. The survival data of 
the kidney transplants between HL-A- matched sibling transplants provide conclusive proof that this is the main histocompatibility system in man. In the present state of tissue typing, im­munologic failures can virtually be eliminated by using HL-A-identical sib­lings. Very low levels of immunosup­pression are adequate for long-term survival of these HL-A-identical trans­plants. However, a certain degree of scepticism exists, mainly among sur­geons, concerning the role of this sys­tem in unrelated cadaver donor trans­plants.Several explanations can be given for the failure to detect a correlation be­
tween tissue typing and clinical outcome in cadaver donor transplants. First, antigens of the HL-A system are com­plex and heterogenous as evidenced by stimulation in mixed leukocyte culture (MLC) tests between HL-A-identical unrelated individuals. Thus, it is now evident that in unrelated individuals, phenotypic identity for HL-A antigens is not equivalent to genotypic identity. Also, other genetic systems may exert a major influence on transplant sur­vival. If this is the case, these systems must be closely linked with genetic determinants for HL-A. This conclu­sion of close linkage between other sys­tems and the HL-A system is based on the highly significant correlation be­tween tissue typing and transplant sur­vival in HL-A-identical siblings. It is still not clear how much influence cross­reactivity between donor and recipient antigens may have on the clinical out­come of transplants. Incompatibility for as yet undetected antigens could also result in this lack of correlation. In addition, technical tissue-typing prob­lems are frequent with cadaver donors, especially when lymphocyte suspensions are contaminated with granulocytes. In view of these complexities it is not sur­prising that the full potential of tissue typing in cadaver transplants is yet to be realized. There is, however, no doubt that tissue typing, properly performed, will play an increasingly important role in determining allograft survival in the future.
Present donor-recipient matching schemes cannot adequately predict the clinical outcome in transplants from unrelated donors. Hors et al.10 recently introduced a donor-recipient matching scheme which has two advantages over the earlier protocols. It takes into ac­count the probability of incompatibility due to serologically undetected antigens and incompatibility due to the cross­reacting antigens belonging to a series. For one locus, the maximum number of detectable antigens in both recipient and donor is four, and the maximum number of incompatibilities is two. In
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each case total incompatibility is cal­
culated locus by locus. Another histo­
compatibility grading system, proposed 
by Terasaki and Mickey,19 consists of 
the calculation of the probability of 
acceptance of given donor antigens or 
haplotype by those of the recipient 
based on earlier data experience. Opelz 
and Terasaki27 have recently proposed a 
new matching scheme which takes into 
account the immunologic reactivity in­
duced in the recipient by primary ex­
posures to pregnancies and transfu­
sions. Consequently the entire em­
phasis of histocompatibility testing is 
shifting to monitoring the effects of 
transfusions in the period before hos­
pitalization. Five classes of reactivity 
are described based on assays for 
humoral cytotoxic antibodies. The un­
responsive patients in class I (without 
cytotoxins for more than one year) had 
significantly superior survival to re­
sponsive recipients in class V  (hyper- 
immunized patients with cytotoxin 
against 50%  to 100%  of random cells). 
The suitability of these matching 
schemes for selection of optimal donors 
remains to be investigated.
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R esu m e
L’auteur etablih la valeur du typage des tis- 
sus pour les antigenes HL-A dans les homo­
transplantations cliniques et base notamment
son opinion sur une abondante litterature. On 
a maintenant une preuve incontestable que 
les antigenes HL-A sont en fait des antigenes 
de transplantation, qui jouent un role primor­
dial dans la survie de l’allogreffe.
Meme si on sait aujourd’hui que les epreuves 
d’histocompatibilite sont indispensables a la 
survie de i’allogreffe et a l’evolution clinique 
du malade, il ne faut pas se dissimuler qu’il 
reste encore un long chemin a parcourir dans 
ce domaine. Evaluer la force comparative de 
chaque antigene HL-A, definir avec plus de 
precision les antigenes connus, elucider des 
questions sur d’autres antigenes, tant sur les 
HL-A que sur d’autres loci, et preeiser leur 
relation genetique, mettre au point une me- 
thode convenable d’appariement de l’histocom- 
patibilite tissulaire entre donneur et receveur, 
sont autant de questions capitales sur lesquel- 
les doivent se pencher les chercheurs.
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INCIDENCE OF DIARRHEA 
FOLLOWING ILEAL RESECTION
GEOFFREY N. TSE, M.B., B.S., F.R.C.S.[C],*
W. GORDON BEATTIE, M.D., F.R.C.S.[G], F.A.C.S.t and 
W. GRANT THOMPSON, M.D., F.R.C.P.[C],t Ottawa, Ont.
The ileum is the site of bile-salt absorp­
tion.1 Ileal resection or bypass leads to 
bile-salt malabsorption, and the result­
ing increased concentration of bile salts 
in the colon stimulates colonic motil­
ity,2' 3 interferes with water and elec­
trolyte absorption4 and may cause diar­
rhea.5 The purpose of this study is to 
estimate the incidence of cholerrheic 
diarrhea following ileal resection.
M aterials  a n d  M ethods
All charts in the Medical Records De­
partment of the Ottawa Civic Hospital, 
Ottawa, Ontario, between 1961 and 1969 
inclusive were surveyed retrospectively, 
and 129 patients were found who had 
ileal resection or bypass. These included 
patients with hemicolectomy and ileal 
conduit but not ileostomy' or colostomy. 
In 95 of the 129 patients, data from the 
case records, questionnaires to doctors 
and patients, and interviews were ade­
quate to determine the characteristics 
of the bowel habit postoperatively.
For the purpose of this study, diar­
rhea is defined as at least two unformed 
liquid stools daily or three movements 
of any consistency daily. Unless a speci­
fic diagnosis of active regional enteritis 
or bacterial enterocolitis was made by 
the attending physician, the diarrhea 
was considered non-specific.
The length of ileum resected was 
based on measurements taken at patho­
logical examination. The diagnoses for 
which the resections were undertaken 
are indicated in Table I.
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TABLE 1.—D iagnosis in 95 Patients W ith Ileal 
R esection
Postoperative non-specific 
diarrhea
Diagnosis
No. of 
cases Persistent
Remission 
within 1 year
Malignancy 42 1 4
Crohn’s disease 
Bowel
15 9 4
strangulation 13 3 3
Ileal conduits 
Congenital
7 1 3
anomalies 
Traumatic lace-
6 1
rations
Carcinoid
2 1
tumours 2 1 1
Radiation necrosis 2 
Miscellaneous 6
1 1
95 16 18
R esults
Thirty-four of the 95 patients with 
ileal resection had non-specific diarrhea 
by the criteria stated above. In 16, this 
was persistent and present for at least 
one year. The remaining 18 patients 
had a spontaneous remission within a 
year (Table I).
Diarrhea did not develop in the 25 pa­
tients who had less than 10 cm. of ileum 
excluded. Nine of 29 patients who had 
10 to 20 cm. excluded had postoperative 
diarrhea; in only three of these did it 
last for more than one year. However, 
of the 41 patients in whom segments 
greater than 20 cm. were excluded, 25 
had diarrhea, and in 13 it was persist­
ent and lasted at least one year.
With ileoileal anastomosis, the ileo­
cecal valve and a segment of terminal 
ileum were preserved. Thirty-seven of 
the 95 patients had such an anastomo­
sis; 10 had postoperative diarrhea. In 
only one of these was the diarrhea per­
sistent. On the other hand, 58 patients 
had an ileocolic anastomosis and 24 had 
diarrhea. In 15 of these patients the 
diarrhea persisted for at least one year.
Table I indicates that diarrhea is
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roost likely to develop following opera­
tion for Crohn’s disease or strangula­
tion, and was unusual following surgery 
for malignancy.
Discussion
Non-specific diarrhea was found to 
occur in approximately one-third of 95 
patients undergoing ileal resection or 
bypass. The most probable mechanism 
underlying this diarrhea was stimula­
tion of the colon by malabsorbed bile 
salts,5' 6 here called “chollerrheic diar­
rhea.”7
If long segments of ileum were re­
moved diarrhea, particularly the per­
sistent type, was more likely. This was 
true also if the ileocecal valve was sacri­
ficed. This may be because the ileocecal 
valve controls the release of chyme into 
the colon, or because the short segment 
of ileum remaining is sufficient to reab­
sorb some bile salts.
The incidence of diarrhea following 
ileal resection for malignancy may be 
low compared with that after Crohn’s 
disease or strangulation because less 
ileum was removed in these cases.
ded by a higher incidence of postoper­
ative diarrhea, particularly of the per­
sistent variety.
We thank Mrs. Nancy McGee and Mrs. Mari­
lyn Clark for secretarial assistance. Mr. H. L. 
Rossman, a medical student, was responsible 
for the initial screening of the hospital charts.
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Summary
One hundred and twenty-nine pati­
ents had ileal resection or bypass at the 
Ottawa Civic Hospital between 1961 and 
1969. The records of 95 contained suf­
ficient data for review, and of these, 34 
had non-specific diarrhea. In 16 of these 
patients the diarrhea was persistent 
and lasted at least one year. Sacrifice of 
the ileocecal valve and resection of 
greater than 20 cm. of ileum was atten­
R £ su m e
Les auteurs ont passe en revue les dossiers 
de 129 malades ayant subi une resection d’ileon 
a I’Hopital Civique d’Ottawa de 1961 a 1969. 
Les dossiers de 95 de ces operes contenaient 
assez de renseignements pour tirer des conclu­
sions. Parmi eux, 34 avaient presente une diar­
rhee non-specifique. Chez 16 de ces 34 malades 
cette diarrhee etait persistante et avait dure 
au moms une annee. Les auteurs ont remarque 
que la resection de la valvule ileo-caecale et 
de plus de 20 cm d’ileon se traduisait par une 
frequence plus elevee de diarrhee postopera- 
toire, particulierement de la forme persis­
tante.
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CHOLESTYRAMINE TREATMENT OF ILEAL EXCLUSION DIARRHEA
W . GRANT THOMPSON, M.D., F.R.C.P.[C],* G. N. TSE, M.B., B.S., F.R.C.S.[C]f and 
W. G. BEATTIE, M.D., F.R.C.S.[C], F.A.C.S..J Ottawa, Ont.
D ia r r h e a  occurs in about one-third of 
patients with ileal resection and persists 
in one-sixth.1 Cholestyramine, a bile- 
salt-sequestering resin, has been used to 
treat hypercholesterolemia and the pru­
ritus of obstructive jaundice.2 Hofmann 
and Poley3 found that cholestyramine, 
16 g. daily, relieved postileal resection 
diarrhea. Our study assessed the effi­
cacy of low doses of cholestyramine in 
controlling persistent diarrhea follow­
ing ileal resection.
M a t e r ia l  a n d  M e th o d
Fifteen patients with persistent diar­
rhea of at least one year’s duration, 
which followed ileal resection one to 16 
years earlier, entered the study. The 
average length of ileum resected was 
56 cm. (Table I). The anastomosis was 
in the ascending colon in six patients, 
the transverse colon in five, the descen­
ding or sigmoid colon in three, and the 
ileum in one. The patients’ ages ranged 
from 16 to 80 years (average 41 years), 
and there were four men and 11 women.
Diarrhea was arbitrarily defined as 
at least two unformed liquid stools or 
three stools of any consistency each 
day. All patients had recognized a de­
finite deterioration in their bowel habit 
following operation. The average stool 
frequency was 5.5/day. In Table I, stool 
consistency was graded from 0 to 3 (0 
formed, 1 soft, 2 loose and 3 watery). 
Fourteen of the 15 patients had watery 
stools, while in the fifteenth they were 
loose.
Before the study, the patients under­
went a careful history and physical 
examination to rule out specific causes 
of the diarrhea. Each patient kept a
‘ Assistant Professor of Medicine, University 
of Ottawa; Gastroenterologist, Ottawa Civic 
Hospital, Ottawa, Ont.
fMcLaughlin Travelling Fellow.
'.[Professor of Surgery, University of Ottawa; 
Chief, Department of Surgery, Ottawa Civic 
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diary in which he recorded the frequen­
cy and consistency of bowel movements 
and the presence of perianal burning, 
urgency and gas per rectum. During a 
one-week control period, a Schilling 
test and three-day stool fat collection 
were done.
Because the taste of cholestyramine 
cannot be imitated or disguised, the pa­
tients were told that they would be 
treated with two different drugs. Each 
received 6 g. daily of either cholestyra­
mine or cornstarch in random fashion. 
If constipation developed, the dose was 
reduced, and if the drug was only par­
tially successful, it was increased. The 
patients were seen alternately by two 
observers who did not know which drug 
was being given. If diarrhea persisted, 
the second drug was begun after one 
week and continued for four weeks. If 
the diarrhea improved on the first 
drug, the agent was continued for four 
weeks, and then a one-week trial with 
the second drug was carried out. During 
the last week of treatment with the 
drug that was given for four weeks, 
stool-fat estimations and Schilling 
tests were repeated.
The stool fat was measured by a 
modification of the van de Earner meth­
od.1 Vitamin B12 absorption was meas­
ured by the Schilling test.5 T-testing 
was done on paired differences of these 
values with each patient acting as his 
own control.
R e s u l t s
Thirteen patients had a 50% reduc­
tion in stool frequency while on choles­
tyramine (Table I). One patient (no. 
6) did not have a reduction in her 
twice-daily bowel movement but noted 
a change in consistency from watery to 
well formed. Although the last patient 
(no. 10) had a reduction in her daily 
bowel movements from 10 to five on 
cholestyramine, they remained at six 
per day when the cornstarch placebo
TABLE I. —  Data in 15 Patients With Ileal Exclusion D iarrhea
Bowel Stool 72-hr. 72-hr. Schilling D aily
frequency consistency stool weight stool fat test dose
{per day) {see text) (g.) (g.) (% ) o f
cholesty-Patient Sex/Age resection distal
Control
Choles- Choles- Choles- Choles-no. {years) {cm .) anastomosis tyramine Control tyramine Control tyramine Control tyramine Control tyramine (g.)
i . M /3 3 48 T ransverse
colon
6 2 3 0 1397 959 13.8 7.5 4.7 0.76 6
2. F /5 4 67 A scending
colon
8 4 2 2 1074 1368 14.6 5.1 12.2 16.9 3
3.
4.
F /2 5 42 A scending
co lon
4 1 3 0 4291 1044 1.7 4.2 18.5 27.9 4
M /3 6 60 A scending
colon
4 . 2 3 1 505 993 8.4 4.2 6.7 13.8 3
5. M /5 0 95 Transverse
co lon
8 3 3 1 1568 1593 7.5 7.5 2.4 3.7 9
6. F /4 2 13 A scending
colon
2 2 3 0 629 867 2.1 1.7 20.5 19.6 3
7. F /1 6 63 A scending
colon
4 1 3 0 1523 829 13.0 9.5 5.4 6.2 6
8. M /3 7 21 D escend ing
colon
5 2 3 2 2105 1224 4.6 3.6 8.6 11.6 6
9.
10.
F /4 5 60 S igm oid
colon
6 3 3 0 1097 641 11.9 10.8 2.67 7.3 6
F /2 9
F /5 3
26 R e c to ­
sigm oid
6 5 3 2 1354 2480 2.7 4.2 11.2 18.5 9
11. — Transverse
colon
6 1 3 0 418 420 10.0 9.5 10.9 12.5 6
12.
13.
F /8 0 70 Transverse
colon
10 2 3 1 3371 537 7.6 5.2 1.2 1.8 6
F /4 5 46 Transverse
colon
4 2 3 0 1362 618 7.7 7 .5 5.86 13.6 6
14. F /4 2 125 Ileum 8 2 3 0 1829 1643 12.9 4.1 10.8 16.4 6
15. F /2 8 56 A scending
colon
3 1 3 0 936 N /A 3.5 N /A 9.25 13.0 2
M E A N 56 5.5 2.2 1609 1087 8.5 6.0 8.7 12.2 5.4
P  >  .05 P  <  .05 P  <  .01
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was substituted. The average dose of 
cholestyramine was 5.4 g./day.
Fourteen patients had watery stool 
on the placebo, and all noted improve­
ment on cholestyramine. In nine of 
these the movements became formed. 
Patient no. 2 noted no change in the 
consistency of her loose stools, but had 
a 50% reduction in frequency on the 
resin. Patient no. 4 had a reduction in 
stool frequency from four to two on 
cholestyramine, and his watery move­
ments became formed. However, he de­
veloped a relapse in his regional ileitis 
after 12 days of treatment. Patient no. 
10, who had an ileosigmoid anastomosis, 
had a poor response, but the other seven 
patients with transverse or descending 
ileocolostomies did well on cholestyra­
mine.
Eight patients complained of exces­
sive gas per rectum before treatment. 
All reported improvement in this symp­
tom on cholestyramine.
All 15 patients complained of peria­
nal burning initially. Twelve had com­
plete relief and three partial relief. All 
of the 11 patients who complained of 
urgency or tenesmus were improved by 
cholestyramine.
The three-day stool weight (Table I) 
was reduced in seven patients, and not 
changed by more than 300 g. in five. 
Patient no. 4, who had a relapse in his 
regional enteritis, and patient no. 10 each 
had a greater than 300-g. increase in 
stool weight. Figures are not available 
for patient no. 15.
Nine of 10 patients who had more 
than 45 cm. of ileum resected had over 
5 g. of fat in the stool per day, while all 
four patients with shorter resections 
had less than 5 g. of stool fat per day. 
Length of resection is not known in pa­
tient no. 11. There was a significant 
overall improvement in fat absorption 
in 14 patients treated with cholestyra­
mine (Pc.05).
Eight of the 10 patients in whom over 
45 cm. of ileum was resected had ab­
normal Schilling tests (less than 10 % 
of the administered activity in the 
urine). One of the exceptions (no. 14)
had 125 cm. resected, but the ileocecal 
valve and 4 cm. of terminal ileum re­
mained. Of the four patients with less 
than 45 cm. resected, three were normal. 
Cholestyramine treatment caused a 
significant improvement in vitamin B12 
absorption in these 15 patients (P<.01).
Discussion
Bile salts irritate the colon in anim­
als6' 7 and interfere with electrolyte ab­
sorption in the human colon.8 Cholesty­
ramine,® by sequestering bile salts, pre­
vents this effect and accounts for the 
improvement noted in our patients. This 
improvement was achieved with an 
average dose of 5.4 g./day—one-third 
the dose used by Hofmann and Poley.3
It has been suggested that bile salts 
exert their cathartic action on the 
proximal colon.3 However, five of our 
patients who responded to cholestyra­
mine had an ileotransverse colostomy, 
and two more had an ileodescending 
colostomy. It appears that bile salts 
exert their cathartic action on the 
transverse and descending as well as 
the ascending colon.
Presumably, cholestyramine relieves 
the pruritus of obstructive jaundice, 
by binding bile salts in the gastrointes­
tinal tract.2 Whether this accounts for 
the relief of perianal soreness in our 
patients, or whether it is due to dec­
reased stool water is uncertain. The re­
lief of urgency or tenesmus may be ex­
plained by the reduction in colon motil­
ity resulting from bile-salt sequestra­
tion. The subjective improvement in 
flatulence is unexplained.
In their patients, Hofmann and Poley 
demonstrated that if more than 100 cm. 
of ileum had been removed, stool-fat ex­
cretion was greater than 20 g./day and 
response to cholestyramine unlikely. One 
of our patients had 125 cm. of ileum re­
sected but still had 4 cm. of terminal 
ileum. This may explain why the stool 
fat was only 12.9 g./day and why the 
patient not only responded to cholesty­
ramine but had a normal vitamin B12 
absorption as well. However, in our 15 
patients we found that if more than 45
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cm. of terminal ileum was removed, 
malabsorption of fat and vitamin B12 
was common, whereas absorption was 
usually normal with lesser resections.
Middleton and Thompson® suggested 
that rapid transit time may be respon­
sible for the steatorrhea of hyperthy­
roidism. The small doses of cholestyra­
mine used in our patients, because they 
controlled the diarrhea and slowed the 
transit time, may have increased the fat 
absorption. If this does occur, it could 
outweigh the steatorrhea-inducing ef­
fect of larger doses of cholestyramine 
noted by Hofmann and Poley.3
Spenney and Hirschowitz10 observed 
increased vitamin B12 absorption in six 
normal subjects and one of three pa­
tients with ileal disease when treated 
with cholestyramine. They suggested 
that the enhancement of vitamin B12 ab­
sorption is due to binding of bile salts 
which ordinarily interfere. The in­
creased vitamin B12 absorption in our 
patients may be partially explained by 
the slowed gastrointestinal transit time.
S u m m a r y
Fifteen patients with persistent diar­
rhea of more than one year’s duration 
following ileal resection underwent a 
double blind trial, alternating cholesty­
ramine and placebo. Thirteen had a 
50% reduction in stool frequency and 
14 had an improvement in consistency 
on an average dose of 5.4 g. of choles­
tyramine per day. Urgency, perianal 
soreness and flatus also decreased in 
most cases. Seven patients whose 
anastomosis was beyond the ascending 
colon also responded. If more than 45 
cm. of terminal ileum was removed, fat 
and vitamin B12 malabsorption was 
likely. Fat and B12 absorption improved 
with this small dose of cholestyramine.
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R e su m e
Chez 15 malades souffrant d’une diarrhee 
persistante d’une duree superieure a un an, 
apres resection d’une portion d’ileon, les au­
teurs ont procede a des essais a double incon- 
nue faisant alterner l’administration de choles­
tyramine, et de placebo. Sous l’influence d’un 
dose quotidienne moyenne de 5.4 g  de choles­
tyramine, 13 des malades ont obtenu une 
reduction de 50% de la frequence des selles 
et 14 une amelioration de la consistance 
des selles. Le caractere pressant des evacua- 
tions, l’endolorissement de la region peri-anale 
et la flatulence ont egalement diminue dans 
la majorite des cas ont egalement reagi a ce 
traitement. Sept malades dont l’anastomose 
etait situee au-dela du colon ascendant. Dans 
les cas ou on avait reseque plus de 45 cm 
d’ileon terminal, il y avait probability d’une 
malabsorption de lipides et de vitamine B12. La 
faible dose de cholestyramine utilisee a ete 
suffisante pour ameliorer l’absorption des lipi­
des et de la vitamine B12.
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PRIMARY MALIGNANT MELANOMA OF THE ESOPHAGUS:A CASE REPORT
ROBERT C. MOFFAT, M.D., F.R.C.S.[C],* LANCE B. RICHARD, M.D.f and J. ERNEST GNASS, M.D..J Trail, B.C.
Ma lig n a n t  melanoma of the esophagus is a rare and unusual tumour; indeed, many authorities doubt whether it can occur as a primary lesion in this par­ticular location. Since the first report in 1906, 31 instances have been re­ported, including one in a child.1 We re­cently had under our care a 54-year-old man who died from generalized me- tastases from a primary malignant me­lanoma of the esophagus. This is only the second such case report in Canada.
Case  R eport
A 54-year-old male Caucasian was admit­ted to the Mater Misericordiae Hospital in Rossland, British Columbia, on May 24, 1970. His main complaints were lethargy, anorexia, hiccoughs and a weight loss of over 20 lbs. during the previous two months. He admitted to some difficulty in swallow­ing solid foods, but his complaints in this regard were not pronounced. Fluids pre­sented no difficulties and solid foods usual­ly produced hiccoughs. He denied any nausea and vomiting, but did complain of occasional pain in his left posterior chest, particularly in the left periscapular area. The patient had been a heavy cigarette smoker for many years.This man had a subtotal thyroidectomy for hyperthyroidism in 1968. At that time an upper gastrointestinal series, including the esophagus, was reported as normal. Re­trospective evaluation of these films con­firmed this impression.In 1968 several hypertrophied lymph nodes were excised from his left axilla. The pathology of these nodes has also been reviewed in retrospect and has confirmed the original diagnosis of reactive hyper­plasia. At no time had he had any skin lesions excised.On physical examination there was evi­dence of considerable weight loss, but no other pertinent physical findings. The liver was not palpable and there was no obvious lymphadenopathy. Rectal and sigmoido-
*Box 1167, North Bay, Ont.fC. S. Williams Clinic, Trail, B.C.JTrail Regional Hospital, Trail, B.C.
Fig. 1.—Radiograph demonstrating the large, bulky, partially obstructing, filling defect in the lower one-third of the esophagus.
scopic examinations were negative. His he­moglobin was 14.0 g./lOO ml.; urinalysis was negative; sedimentation rate was 46 mm. in one hour (Westergren) ; total serum bilirubin was 0.4 mg./lOO ml.; blood urea nitrogen was 12 mg./lOO ml.; fasting blood sugar was 103 mg./lOO ml.; alkaline phos­phatase was 6 Bodansky units; serum glu­tamic oxaloacetic transaminase (SGOT) was 34 units/ml.; total serum protein was 6.7 g./lOO ml. (albumin 4.4 g./lOO ml., glo­bulin 2.3 g./lOO ml.).The chest films and the barium enema examinations were within normal limits. The upper gastrointestinal series revealed an irregular, polypoid bulky mass in the distal one-third of the esophagus. As is evident in Fig. 1, it manifested itself as a large partially obstructing filling defect, which extended throughout most of the lower one-third of the esophagus. Also evi­dence of extrinsic pressure on the esophagus suggested nodal enlargement.
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During esophagoscopy, a large tumour 
mass was visualized approximately 30 cm. 
from the incisors and was biopsied. The 
original pathological diagnosis was that of 
a heavily infected infiltrating squamous­
cell carcinoma, Grade 3. In the specimen, 
much of the tissue had been destroyed by 
the tumour, hence the correct diagnosis, 
melanoma, could not be made on the tissue 
submitted. An exploratory laparotomy and 
left thoracotomy were performed in the hope 
that some type of palliative bypass proce­
dure would be feasible. However, the liver 
contained many small metastatic nodules 
that were easily palpable. None of these 
was larger than 1 cm. and a biopsy of one 
revealed a malignant lesion with only a 
small amount of pigment. The lung con­
tained multiple, small and dark nodules 
which suggested malignant melanoma. Sub­
sequent sections revealed pigment which 
gave a positive histochemical reaction for 
melanin. The esophageal tumour itself had 
invaded the left hilum and hence no bypass 
procedure seemed feasible. We did a gastro­
stomy and closed the incisions.
With a pathological diagnosis of malig­
nant melanoma, we questioned him again to 
confirm that he had never had any skin 
lesions removed and again examined the 
various common primary sites for malig­
nant melanoma such as the skin, eyes, anus, 
rectum and genitalia. We even considered 
rare sites such as the leptomeninges, naso­
pharynx and bronchi. No other plausible 
primary source was identified.
Because of the generalized metastases the 
patient’s hospital course was rapidly down­
hill. He died on September 25, 1970, four 
months from the day of diagnosis.
At autopsy, the esophagus contained a 
dark tumour 17 cm. long and up to 6.0 cm. 
wide arising from the junction of the lower 
and middle one-third (Fig. 2). The tumour 
adhered to the esophageal mucosa and had 
fungated into the lumen. It did not pene­
trate deeply into the esophageal wall and 
adhered to only one-third of the circum­
ference. The primary was by far the largest 
tumour mass. He had numerous metastases 
in the lungs, consisting of nodules which 
averaged 2.0 cm. in diameter. There were 
metastases in the brain and in the various 
other abdominal organs, including liver, 
adrenals, stomach, etc. He also had second­
ary deposits in the lip and scalp.
Certain workers2'5 have attempted to set 
up histologic criteria for the pathological 
diagnosis of primary malignant melanoma
Fig. 2.—The primary site of the malignant 
melanoma is in the lower one-third of the eso­
phagus. Note the fungating growth which in­
volves only a portion of esophageal circum­
ference. Several punctate gastric secondary 
lesions can also be seen.
of the esophagus based on junctional 
changes in the epithelium. Demonstrable 
changes provide reasonable proof of the 
diagnosis, but the absence of such changes 
does not exclude the diagnosis because a 
rapidly expanding neoplasm may destroy 
evidence of such changes before death or 
biopsy. Several slides from our specimen 
demonstrated junctional changes.
Microscopically these lesions had a pleo­
morphic appearance, namely, large oval 
and polygonal “ epithelioid cells”  and 
smaller slender “sarcomatoid areas”  (Figs. 
3 and 4). A special stain for melanin was 
positive. Only about 5% of sections taken 
from the esophageal mucosa at some dis­
tance from the tumour mass revealed 
areas with junctional changes. Although 
the submucosa contained numerous mela­
nin-containing phagocytes, the pathologist 
did not regard these as necessarily related 
to the junctional changes because the mel­
anin production in the tumour itself would 
be sufficient to explain their occurrence. 
These junctional changes, which covered 
areas up to 1.0 cm. long, were usually 
limited to the basal layer. However, a few 
foci showed greater activity, as Figs. 3 
and 4 show.
D is c u s s io n
Malignant melanoma o f the eso­
phagus is most unusual and many w ork­
ers deny that such a tumour can arise 
from  this organ as a prim ary lesion. 
Piccone et al.5 reviewed the literature, 
which contains over 30 published re-
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Fig. 3.—Photomicrograph showing an area with junctional changes. Note that the under­
lying submucosa is not infiltrated by tumour tissue (H & E X 35).
Fig. 4.—Nevus cells and junctional changes in the mucosa of the esophagus some distance 
from the primary tumour. Several nevus cells are seen beyond the basal layer, particularly to 
the left side of the photomicrograph. When seen in the skin these changes would be interpreted 
as a junction nevus (H & E, original magnification X  450).
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ports of malignant melanoma of the eso­
phagus in which no other primary site 
was evident, and called into question the 
pathological criteria for diagnosis in 
many of the reports. However, the rari­
ty with which malignant melanoma me­
tastasizes to the esophagus from other 
sources strengthens the possibility that 
the lesion arises there. The literature 
that we have reviewed contains only two 
cases of melanoma metastasizing to the 
esophagus.8,7 Burnett and St. John8 re­
viewed 22,000 autopsies at the Johns 
Hopkins Hospital and, although they 
found 25 malignant melanomas at vari­
ous sites, they did not find a single me­
tastasis or primary in the esophagus. 
Also, several authors3,9 have reported 
that normal esophageal epithelium does 
occasionally contain melanin pigment. 
In a study of non-selective esophagi, De 
la Pava et al.3 found typical melano- 
blasts with melanin granules and den­
drites in the basal layer of a normal 
esophageal epithelium in several of 
their specimens. Pomeranz and Gar- 
lock10 believe that malignant melanoma 
probably originates in the melanoblast 
—the dendritic cell.
Recently Loring and Zeppa11 and 
Raven and Dawson12 have reviewed the 
clinical and pathological features of this 
tumour. Patients generally present with 
dysphagia, but not always. In the pa­
tient described here, dysphagia, a late 
symptom, was preceded by significant 
weight loss, subscapular pain and hic­
coughs. The most common location of 
this tumour is the middle and lower one- 
third of the esophagus, and rapid gen­
eralized metastases with a fulminating 
downhill course are the usual sequence 
of events. Unfortunately, this man’s 
lesion was not resectable and, anyway, 
the results of resection are still poor.
S u m m a r y
A 54-year-old white man had malig­
nant melanoma arising in the esopha­
gus. Two clinical points in support of 
such a lesion arising from esophageal 
epithelium are the relatively large size 
of the growth compared with the size
of the many metastases, and the known 
rarity with which malignant melanoma 
of any site metastasizes to the eso­
phagus. The histologic demonstration of 
junctional cells in other areas o f the 
esophageal epithelium some distance 
from the primary tumour suggests the 
tumour originated from this structure.
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R e s u m e
Un homme de 54 ans, de race blanche, pre- 
sentait un melanome malin survenant dans 
l’oesophage. Deux elements cliniques permet- 
tent de confirmer que cette lesion provenait 
de l ’epithelium oesophagien: d’une part la 
taille relativement considerable de la tumeur, 
par comparaison avec la taille des nombreuses 
metastases et d autre part, la raretd bien con- 
nue avec laquelle un melanome malin siegeant 
n’importe ou essaime vers l’oesophage. Enfin, 
la decouverte histologique de cellules de jonc- 
tion en d’autres regions de l’oesophage, a une 
certaine distance de la tumeur principale, per- 
met d’affirmer que celle-ci avait bien son 
origine dans cette structure anatomique.
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PARENTERAL HYPERALIMENTATION IN MANAGEMENT OF GASTROINTESTINAL FISTULAS*
GEORGE M. W EISZ, M.D.,f GERALD S. MOSS, M.D., F.A.C.S.J and FRANK A. FOLK, M.D., F.A.C.S.,§ Chicago, III,, U.S.A.
The continuous secretion of duodenal and pancreatic juices with their proteo­lytic enzymes militates against the heal­ing of gastrointestinal fistulas due to trauma or surgery. The skin surround­ing the stoma of the fistula becomes sev­erely eroded. Water and acid-base im­balance complicates the clinical course, with the loss of electrolyte-containing 
fluids. Protein catabolism debilitates the patient, lowers his resistance and, hence, sepsis is a common preterminal complication.
In the past, several methods of redu­cing duodenal and pancreatic secretion have been tried : dietetic treatment with low carbohydrate and protein but high fat intake; the parasympatholytic effect of atropine; adrenergic stimulation using ephedrine sulfate; cholinergic drugs such as methantheline bromide and propantheline bromide ;1_3 inhibitors of carbonic anhydrase such as acetazola- mide; and ethyl alcohol.1’4> 5 Each of these methods had drawbacks.Further physiologic studies on the stimulation of external secretions of the pancreas suggested that a high serum glucose level—400 mg./lOO ml. or higher—might inhibit such secretion.6It was then found that rapid depres­sion of external pancreatic secretion can be obtained by glucagon infusion, which inhibits 90% of the secretion.7The physiologic basis for the preven­tion and management of pancreatic fis­tulas has been reviewed elsewhere.8Parenteral hyperalimentation re­presents a significant step forward in the development of surgical nutrition
‘ From  the T raum a Unit, Cook County Hos­p ital, Chicago, 111.
fD epartm ent of Surgery, Rambam Hospital, Aba Khoushy Medical School, H aifa, Israel.
{Associate Professor of Surgery, Abraham  Lincoln School of Medicine, U niversity of Illi­nois, Chicago, 111.
§Associate Professor of Surgery, Loyola School of Medicine, Chicago, 111.
Fig. 1.—Preparation tion regimen.
60  mEq. 44 mEq. 10 ml.
of the hyperalim enta-
and the management of the severely ill patient.9,10Thomas and Ross," in 1948, reported complete closure of a pancreatic fistula by continuous parenteral feeding of concentrated dextrose and an amino acid solution (Amigen). Based on this report Dudrick et al.1* have applied parenteral hyperalimentation to the management of digestive tract fistulas.The purpose of this paper is to de­scribe two patients with pancreatico­duodenal fistulas successfully treated with parenteral hyperalimentation.
P r e p a r a t io n  a n d  A d m in is t r a t io n  o f 
H y p e r a l im e n t a t io n  F l u id
The different solutions are mixed in a sterile vacuumized bottle of 2000-ml. capacity by the closed method (Fig. 1). The solution contains 1000 ml. of 5% Amigen dextrose (Baxter Laboratories) in addition to 500 ml. of 50% dextrose. Basic metabolic requirements are cov­ered by the addition of one ampule of sodium bicarbonate (44 mEq.), 60 mEq. of potassium chloride and 10 ml. of a multivitamin solution (complex B, vita­mins A, C, and D). Magnesium is ad­ministered intramuscularly.13 One unit (1500 c.c.) of this solution yields 1400 calories.
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This hypertonic solution is infused 
over an eight- to 12-hour period into 
the superior vena cava through an in­
dwelling polyvinyl catheter, inserted 
through the cephalic or subclavian vein. 
The position of the catheter is checked 
radiologically. The metabolic state is 
checked daily by determinations of se­
rum electrolytes, glucose and urea lev­
els, and osmolality of serum and urine. 
Urine volume and glucose excretion are 
checked every four or six hours and, 
when necessary, insulin is administered 
if glycosuria develops.
Care of the infusion site must be car­
ried out aseptically. The catheter should 
be sutured to the skin to prevent in-and- 
out movements. Because the nutrient 
solution is an excellent medium for bac­
terial growth, the infusion set is 
changed daily to prevent septicemia.
A t the Trauma Unit, Cook County 
Hospital, Chicago, two patients with 
pancreaticoduodenal fistulas w e r e  
treated by parenteral hyperalimentation 
to depress pancreatic secretion.
Ca s e  Re p o r t s
Case 1.— A 21-year-old Negro man was 
admitted to the Trauma Unit with an abdo­
minal gunshot wound. Exploratory laparo­
tomy revealed perforation of the stomach, 
head of the pancreas, and the inferior vena 
cava. After a difficult hemostasis and re­
pair of the inferior vena cava, gastrostomy 
and pancreaticojejunostomy (Roux-en-Y) 
were performed and the stomach perfora­
tion was repaired. Sump drainage was 
placed posterior to the unrepaired lacera­
tion of the pancreas as well as anteriorly at 
the site of the pancreaticojejunostomy. Dur­
ing the first five postoperative days the pa­
tient was maintained on intravenous fluid 
intake only. On the sixth day, temperature 
elevation and tachycardia were noticed. The 
sump drainage, which had been declining 
from an initial amount of 50 ml./day, sud­
denly increased to 150 ml. on the fifth post­
operative day and to 500 ml. on the seventh 
day. The secretion showed an amylase ac­
tivity of 12,000 Somogyi units. Intravenous 
hyperalimentation was started with one 
unit during an eight-hour period. The pa­
tient tolerated the infusion well. No elec­
trolyte, acid-base balance or osmolality dis-
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Fig. 2.—Treatment of pancreatic fistula in
Case 1.
turbances appeared. The pancreatic secre­
tion decreased over the next three days to 
50 ml./day, with undetectable amylase ac­
tivity (Fig. 2). The patient continued well 
until the fifteenth postoperative day when 
he died of sepsis, bilateral bronchopneu­
monia, and severe uncontrollable gastroin­
testinal bleeding, in spite of the cessation of 
the pancreatic secretion.
Case 2.— A 28-year-old Negro man was 
admitted to the Trauma Unit with an ab­
dominal gunshot wound. Laparotomy dis­
closed a laceration of the transverse colon, 
duodenum (second part) and inferior vena 
cava. The vein was repaired and the lacera­
tion of the lateral wall at the duodenum 
(0.5 cm. in length) was closed. A gastro­
stomy, a retrograde decompressive jej uno­
stomy and a distal feeding jej unostomy 
were performed. The side of the injured 
colon was exteriorized. In the postoperative 
period he bled from the mesocolon in the 
area of the colostomy. The patient also de­
veloped sepsis, ascending cholangitis, and a 
pulmonary infection. A lateral duodenal fis­
tula appeared in the second week. A month 
later, after the treatment of all complica­
tions, the fistula was still present, eroding 
the surrounding skin area. An upper gas­
trointestinal roentgenogram showed that 
the lumen of the fistula equalled that of the 
duodenum. The gastrostomy tube had 
slipped out. Neither the gastrostomy nor 
feeding jejunostomy sites showed signs of 
healing. The decompressive jejunostomy 
tube was removed because it was ineffect­
ive. Two months after injury, 700 to 800 ml. 
of duodenal secretion was being collected 
daily. The patient had lost approximately 
50 lbs. A three-unit hyperalimentation diet 
was administered daily for the next 15 days. 
The patient gained 24 lbs., started to 
walk, became active, and regained his appe­
tite. All his skin wounds closed and the
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copious fistulous secretion, containing en­zymes and electrolytes, decreased at the rate of 100 ml./day. The lateral duodenal fistula continued to secrete 20 to 30 ml./day for another week and then closed completely. During this week the patient was eating Vivonex (Eaton Laboratories [Division of The Norwich Pharmacal Company, Ltd.], Paris, Ont.), a hypertonic diet,14 for the first three days, and then a regular diet. Three weeks after hyperalimentation was started, a repeat upper gastrointestinal ro­entgenogram showed a normal duodenal pattern.
D iscussion
Many gastrointestinal fistulas have been treated by parenteral hyperalimen­tation since the method was outlined in1970.1416Our two cases, showing successful in­hibition of pancreatic secretion and closure of a duodenal fistula, substan­tiate the efficiency of parenteral hyper­alimentation in a patient who can toler­ate hypertonic glucose infusions.The first patient, who was in the post-traumatic catabolic phase, de­veloped a pancreatic fistula and re­ceived significant benefit from the in­hibition of pancreatic excretion, allow­ing healing of the peritoneal inflamma­tion; unfortunately, he died later from severe bleeding.In the second patient, a continually secreting duodenal fistula interfered with nutrient absorption and wound 
healing. The inhibition of the duodenal secretion allowed rapid anabolism and closure of the wide fistula which, in turn, permitted early feeding by mouth. The patient recovered completely.The mechanism of inhibitory effect of the hypertonic glucose and Amigen solu­tion is obscure. Whether the inhibition of intestinal secretions is achieved by the direct effect of the hyperglycemia or by the effect of dehydration has not yet been established.12 In these cases the blood sugar level rose no higher than 180 mg./lOO ml. and there was no osmotic diuresis. For these reasons, a humoral mechanism is probably respon­sible for the inhibition, rather than de­hydration.
This technique, intravenous hyper­alimentation, deserves a trial in the management of pancreaticoduodenal fis­tulas. An accurate knowledge of the im­pending metabolic disturbances and an awareness of the possibility of septice­mia are imperative in its use. This method can induce early closure of di­gestive fistulas, healing of wounds and 
a positive metabolic balance.For preventive purposes, the hyper­alimentation should be used from the early postoperative days. This should prevent the development of fistulas and, at the same time, accord the patient the benefit of a high caloric intake in the post-traumatic or postoperative period.
S umm ary
This article deals with the pharma­cologic inhibition of gastrointestinal secretions and its clinical application.The development of inhibitors of pan­creatic exocrine secretion is reviewed. The physiologic basis for different die­tetic regimens, the effect of cholinergic drugs, adrenergic stimulants, carbonic anhydrase inhibitors on pancreatic se­cretion are listed. Also mentioned is the discovery of the depressant effect of glucagon and high glucose infusion on the exocrine pancreas, and the clinical application of this last finding, i.e. in­travenous hyperalimentation as a de­pressant of gastrointestinal fistulas. First mentioned by Thomas and Ross in 1948, such alimentation was scienti­fically applied in the management of fistulas by Dudrick et al. in 1970.We used this method in many cases of post-traumatic or postoperative fistu­las. The sterile preparation of the hy­peralimentation regimen is described and graphically illustrated. Two illus­trative cases were chosen for more de­tailed description.A man with pancreatic fistula had a decline of daily pancreatic secretion as a result of the treatment, and another, with duodenal and jejunal fistulas, had a reversal of his severe catabolic state, closure of the fistulas, healing of ab-
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dominal wounds and weight gain lead­
ing to complete recovery.
In conclusion, intravenous hyperali­
mentation, besides providing a high cal­
oric intake, depresses intestinal and 
pancreatic exocrine secretion. This 
method of “ immobilization” rests the 
gastrointestinal tract and should be 
used to manage fistulas and inflamma­
tory processes of the digestive tract and 
its annexes.
We wish to thank the staff of the Depart­
ment of Medical Publications, The Hospital for 
Sick Children, Toronto, for assistance in the 
preparation of this article.
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R e su m e
Le present article traite de l’inhibition phar- 
macologique des secretions gastro-intestinales 
et de son application clinique.
II passe en revue les inhibiteurs de la secre­
tion du pancreas exocrine. On y trouve un aper- 
gu de la base physiologique de differents re­
gimes dietetiques, de Faction des cholinergi- 
ques, des stimulants adrenergiques, des inhibi­
teurs de 1’anhydrase carbonique sur la secre­
tion pancreatique. On y mentionne egalement 
la decouverte de l’effet depresseur du glucagon 
et de la perfusion concentree du glucose sur le 
pancreas exocrine. Les auteurs rappellent l’in- 
dication clinique de cette decouverte, soit l’em- 
ploi d’une hyperalimentation intraveineuse 
comme depresseur des fistules gastro-intesti­
nales. Cite pour la premiere fois par Thomas 
en 1948, ce type d’alimentation a ete applique 
scientifiquement dans le traitement des fis­
tules par Dudrick en 1970.
Les auteurs ont recouru a cette methode 
dans de nombreux cas de fistules post-trauma- 
tiques ou postoperatoires. Ils decrivent, en 
l’illustrant de quelques graphiques, le mode 
de preparation sterile de ce regime d’hyperali- 
mentation. La presentation de deux cas typi- 
ques permettent de donner plus de details.
Chez un homme souffrant d’une fistule pan­
creatique, le debit quotidien diminua et chez 
un autre, porteur de fistules duodenale et je- 
junale, on nota le renversement d’un etat cata- 
bolique severe, la fermeture des fistules et des 
plaies abdominales et un gain de poids.
En conclusion, 1’hyperalimentation intravei­
neuse, outre l’avantage de sa haute valeur 
calorique, permet d’inhiber la secretion intes- 
tinale et celle du pancreas exocrine. Cette me­
thode “d’immobilisation” met au repos le trac- 
tus gastro-intestinal et devrait etre employee 
dans le traitement des fistules et des processus 
inflammatoires de l ’appareil digestif et de ses 
annexes.
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EOSINOPHILIC ENTERITIS OF THE ILEUM: A CASE REPORT*
R. SIVASANKAR, M.D., F.R.C.S.[C], 0. G. LANE, M.D.(Lond.), 
F.R.C.Path. and 0. K. HJERTAAS, B.A., M.D., F.R.C.S.(Edin.),
Prince Albert, Sask.
E o s in o p h il ic  infiltration of the gastro­
intestinal tract is a rare condition. The 
etiology is unknown, the symptoms are 
vague, the diagnosis is rarely made be­
fore operation and therapy is limited to 
relief of symptoms. The following case 
report illustrates some of the features 
of the condition.
C a s e  R epo r t
Mrs. E. A., aged 63 years, was seen in 
August 1970 complaining of crampy ab­
dominal pain and bouts of diarrhea. She had 
lost weight and tired easily. She had had 
these symptoms for about one year.
Her previous history included a gastroen­
terostomy in 1926, cholecystectomy in 1935, 
a partial gastrectomy in 1946 and a hemor­
rhoidectomy in 1957. A hysterectomy was 
performed in 1967 for cervical dysplasia. 
She had received treatment for anemia 
which was attributed to her partial gastrec­
tomy. In 1962 and 1968 she had been ad­
mitted to hospital for crampy abdominal 
pain and diarrhea.
On examination she was thin and, aside 
from this, abnormal findings were limited 
to the abdomen. Several scars from sur­
gical operations were present. There was no 
tenderness but, on palpation, there was a 
vague suggestion of a mass in the right 
lower quadrant.
Laboratory data included hemoglobin of 
12 g./lOO ml., erythrocyte sedimentation 
rate of 10 mm. in one hour (Wintrobe), and 
leukocyte count of 7200./c.mm. A differen­
tial count was not obtained at this time.
A barium enema (Fig. 1) was suggestive 
of regional ileitis. In the differential diag­
nosis we also considered lymphomatous in­
filtration of the small bowel and an as­
sociated polypoid lesion in the cecum.
At laparotomy the terminal ileum was 
diffusely thickened and edematous. The 
cecum itself felt firm and had a feeling of 
fullness, which suggested an intraluminal 
mass. We did a right hemicolectomy.
‘ From the Departments of Surgery and Patho­
logy, Victoria Union Hospital, Prince Albert, 
Sask.
Reprint address: Dr. R. Sivasankar, 110 - 8th 
Street East, Prince Albert, Sask.
Fig. 1.—Barium enema showing irregular 
narrowing of the lumen with coarse distorted 
mucosal folds and polypoid filling defects in­
volving the distal five to six inches of ileum 
and cecum. The ileocecal valve is also enlarged.
Pathology
The specimen consisted of 44.5 cm. of 
distal ileum, the cecum and part of the 
ascending colon (together 17 cm.) with the 
related mesentery attached. The vermiform 
appendix was absent. The terminal ileum 
and cecum were firm and tubular, and the 
serosa was roughened. The mucosa of the 
ileum and cecum was edematous and the 
terminal 15 cm. of the former was studded 
by numerous tiny white nodules (up to ap­
proximately 0.1 cm. in diameter). More dis- 
tally the nodules were slightly larger and at 
the ileocecal valve they were about 0.4 
cm. to 0.5 cm. in diameter. On the cut 
surface, the wall of the terminal ileum and 
cecum was thickened and firm, and the 
muscularis stood cut on a semitranslucent 
greyish background. The lumen was also 
narrowed.
The lymph nodes in the attached mesen­
tery were firm and pale brown and varied 
in size (up to 2 cm. in diameter).
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Fig. 2.—The submucosa is edematous with 
dilated lymphatic vessels and cellular exudate 
(H & E, original magnification X 100).
Microscopic Examination (Figs. 2 and 3)
The walls of the ileum and, to a lesser ex­
tent, the cecum were thickened from edema 
and a cellular exudate involving the sub­
mucosa, the serosa and the muscularis. The 
mucosa was normal. The submucosa and 
serosa contained dilated blood and lymph 
vessels, and the connective tissues were 
eosinophilic and homogeneous. There were 
small pools of liquefaciion degeneration. 
The cellular exudate was composed of in­
numerable eosinophils together with occa­
sional histiocytes and lymphocytes. The 
eosinophilic infiltrate was most striking in 
the serosa and between the tunics of the 
muscularis. Perivascular sites were particu­
larly involved but there was no arterial 
change. Eosinophils were less numerous in 
the sufcmucosa but even here they were 
abundant. In addition there was follicular 
hyperplasia in the submucosal lymphoid tis­
sue and some hypertrophy of the muscularis 
towards the ileocecal valve. Larvae, ova, or 
mature parasites were not identified.
The lymph nodes in the mesentery were 
enlarged by both follicular and sinus hyper-
Fig. 3.—Detail of the cellular exudate in 
which eosinophils are predominant (H & E, 
original magnification X 400).
plasia. The follicles had large germinal cen­
tres and the sinuses contained some eosino­
phils but mostly lymphocytes and plasma - 
cytes. The pathologist concluded that this 
represented eosinophilic enteritis with in­
volvement of the cecum.
This woman’s postoperative course was 
uneventful and when seen three months 
later she was well.
In view of the pathological findings we 
decided to look more closely into her past 
history, and some interesting features 
emerged. In January 1944 she complained 
of epigastric pain and a radiograph made 
elsewhere raised the suspicion of a malig­
nant lesion in the duodenum. We were un­
able to obtain any information on the out­
come of this investigation. However, in 
June 1946, she was admitted to hospital 
with upper abdominal pain and radiologic 
evidence suggestive of a gastric ulcer. A 
partial gastrectomy was performed and we 
examined sections from the specimen. The 
mucosa was normal. The submucosa was 
edematous and heavily infiltrated with eosi­
nophils and some lymphocytes. The eosino­
philic infiltrate extended into the mus-
316 THE CANADIAN JOURNAL OF SURGERY Vol. 15
cularis which was hypertrophied. The serosa 
was not involved. The pathologic changes 
were, in our view, the same as those present 
in the lesion under discussion.
We also ascertained that, on hospital ad­
missions in 1962 and 1968, the leukocyte 
counts were 6950/c.mm. (17% eosinophils) 
and 7850/c.mm. (48%  eosinophils) respect­
ively. In December 1959, when she had a 
hemorrhoidectomy, the leukocyte count was 
6300/c.mm. (9%  eosinophils).
In October 1970, almost one month after 
the present operation, the count was 5500/ 
c.mm. (13%  eosinophils) and in December 
1970 6500/c.mm. (10%  eosinophils). In 
May 1971, her diarrhea had worsened and 
her leukocyte count was 6500/c.mm. with 
25% eosinophils. She was placed on predni­
sone, 5 mg. three times daily, and obtained 
marked symptomatic relief. On June 10, 
1971, her leukocyte count was 10,600/c.mm. 
with no eosinophils.
A trial of cessation of steroid therapy 
was followed by a prompt recurrence of 
diarrhea and she is now on a maintenance 
dose of 7.5 mg. of prednisone daily. When 
last seen, one month ago, she was well.
D iscussion
The literature relating to eosinophilic 
granuloma of the intestinal tract has 
been fully reviewed by Ashby, Appleton 
and Dawson.1
The condition is most frequent in the 
fifth and sixth decades of life but can 
occur in children.2,3 Men are affected 
slightly more often than women. No 
part of the alimentary tract from 
pharynx to rectum is free from invol­
vement.1 Generally, however, the lesions 
are in the gastric antrum or the ter­
minal ileum and in either site may be 
localized or diffuse.1,4 In this particular 
patient, both areas were affected but 
the interval between lesions giving rise 
to symptoms was some 25 years.
The basic pathological lesion is edema 
of the wall of the viscus, particularly the 
submucosa, with dilatation of lymphatic 
and blood vessels and heavy eosinophilic 
exudation.1,3 The process may extend 
into the muscularis and the serosa and 
even be more severe at these sites than 
in the submucosa. However, the changes 
in the submucosa initiate the sequence of
events that lead to symptoms. Gastric 
outlet obstruction may be caused by in­
termittent prolapse of the mucosa which 
sometimes becomes polypoid.4' 5 The 
pylorus can become hypertrophied and 
the pyloric canal narrowed.6 Similar 
changes in the ileum lead to partial 
small intestinal obstruction and oc­
casionally intussusception.2
The etiology of eosinophilic infiltra­
tion of the intestinal tract is as elusive 
as that of regional enteritis. Some of the 
diffuse cases are associated with eosino- 
philia in the peripheral blood.4,7 This 
lesion is sometimes found in patients 
who have asthma, food or drug aller­
gies.3 Ashby, Appleton and Dawson1 
considered the pathologic changes in 
both their cases represented an allergic 
response to infestation by the North Sea 
herring parasite—Eustoma rotunda- 
tum. Their opinion was based on the 
clinical history of their patients and 13 
cases reported by Kuipers, all of whom 
had remnants of parasite larvae in their 
lesions. However, they conceded that the 
parasite does not cause all cases. The 
most frequently offered opinion is 
that the lesions constitute an allergic re- 
sponse.1’5' 7 Because the whole of the ali­
mentary tract is susceptible it is diffi­
cult to reconcile such a view with the 
favourable response of some cases to 
local resection.1,3> 4 Perhaps the follow­
up in these cases has not been continued 
for a long enough period. Our patient 
gave no history suggestive of other al­
lergy and she did not eat uncooked or 
salted herring.
After a careful prolonged study, Lein- 
bach and Rubin8 concluded that eosino­
philic gastroenteritis is not a simple 
process that can be reversed by re­
moving certain food allergens. The re­
sponse is temporary and management 
on an elimination diet is impractical.
Ureles et al.* have proposed a useful 
classification of this condition. The 
primary classification is into the dif­
fuse and circumscribed forms. The 
former is subdivided into the polyen­
teric, monoenteric and regional types. 
The circumscribed forms are sub-
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divided into regional and polypoid types. 
Salient clinical features and histologic 
appearances of each type are described 
in their paper. Our case appears to have 
been of the regional type in the diffuse 
form.
Vanek10 has effectively disposed of the 
view that the lesions are related to eosi­
nophilic granuloma of bone or the an­
alogous conditions of Hand-Schuller- 
Christian and Letterer-Siwe diseases. 
The characteristic features differen­
tiating eosinophilic gastroenteritis from  
histologically similar lesions are de­
scribed by Samter, Alstott and Kurlan- 
deru and Swarts and Young.12
Diagnosis is rarely made before oper­
ation and these patients are usually ex­
plored because of symptoms of obstruc­
tion, suspicion of malignancy, or, as in 
this case, with a tentative diagnosis of 
regional ileitis.
The treatment has usually been re­
section of localized lesions causing ob­
struction of the gastric outlet or small 
bowel. However, it should be strongly 
emphasized that, if diagnosis can be 
made before operation, steroid therapy 
is the treatment of choice, especially for 
the diffuse and recurrent forms of the 
disease.1’ M If the pathologist who re­
ported on the gastric specimen in 1946 
had been aware of this entity and if we 
had entertained the correct diagnosis, 
our patient might have been spared her 
last operation.
S u m m a r y
A  63-year-old women with a pro­
longed history of gastrointestinal com­
plaints was found to have eosinophilic 
enteritis. The main clinical and pathol­
ogical features of the condition are de­
scribed. The authors emphasize that if 
the diagnosis is made before operation, 
steroid therapy is the treatment of 
choice except for obstructive lesions or 
where a malignant lesion cannot be 
ruled out.
The authors wish to thank Mrs. Margaret 
Roy for her secretarial assistance.
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Re su m e
Chez une femme de 63 ans qui se plaignait 
depuis longtemps de malaises de l’appareil di­
gestif, on decouvrit une enterite a eosinophiles. 
Les auteurs en decrivent les principales carac- 
teristiques cliniques et pathologiques. Ils 
soulignent que si le diagnostic est porte 
avant 1’operation, la corticotherapie est le 
traitement par excellence, sauf dans le cas de 
lesions occlusives et dans celui ou il n’est pas 
possible d’eliminer la possibility d’une lesion 
maligne.
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RINGER’S LACTATE INFUSION WITH SEVERE HEPATIC DAMAGE: 
EFFECT ON ARTERIAL LACTATE LEVEL*
S. MYRON GOLDSTEIN, M.D. and LLOYD D. MacLEAN, M.D., F.R.C.S.[C],
Montreal, Que.
In the presence of the shock syndrome, 
regardless of etiology, an elevated ar­
terial lactate has prognostic value.1'6 
This elevation is generally attributed to 
anaerobic metabolism in hypoxic tissue. 
However, Huckabee7 has noted that ar­
terial lactate levels are not determined 
solely by cellular oxygenation but can 
be raised by epinephrine, bicarbonate, 
or pyruvate infusions as well as by 
hyperventilation. Lowery, Cloutier and 
Carey8 showed that Ringer’s lactate was 
as useful as saline in the early resuscita- 
tive period of hypovolemic shock in 
man. Shires et a l demonstrated that 
Ringer’s lactate added to shed blood was 
superior to shed blood alone in the re­
suscitation of shocked dogs.
Lactic acid is metabolized in almost 
all organs, but the liver is the primary 
site. Schumer, Moss and Nyhus10 have 
shown that lactate metabolism is de­
pressed after prolonged hypovolemic 
shock and have speculated that this is 
due to depressed hepatic function. How­
ever, Trinkle, Rush and Eiseman11 dem­
onstrated that Ringer’s lactate infu­
sions are rapidly cleared in dogs after 
hypovolemic shock.
The purpose of this experiment was 
to determine the ability of dogs to 
handle a rapid exogenous, lactate load in 
spite of severe hepatic injury.
Method
Fourteen adult mongrel dogs were 
maintained on a normal kennel diet for 
one week before operation. Under light 
pentobarbital sodium (Nembutal) anes­
thesia the blood supply to the liver was 
isolated by the technique described by 
Farkouh et al.12 and total inflow stasis 
was maintained for 60 minutes in 10
*From the Department of Surgery, Royal Vic­
toria Hospital and McGill University, Mont­
real, Que.
Supported by a grant from the Medical Re­
search Council of Canada.
dogs. The 14 dogs were divided into 
three groups.
Control— Group I
Four dogs were kept under anesthesia 
for five hours and given an infusion of 
1 1. of Ringer’s lactate solution between 
the second and third hours.
Control— Group II
Five dogs underwent 60 minutes of 
total hepatic inflow stasis and were 
given an infusion of 1 1. of 0.9% saline 
during the anhepatic period, viz. the 
time during which the dog was totally 
without hepatic function because no 
blood was flowing through the liver.
Experimental— Group III
Five dogs underwent 60 minutes of 
inflow stasis and were given an infu­
sion of 1 1. of Ringer’s lactate during 
the anhepatic period.
At the end of the anhepatic period, 
hepatic circulation was restored and 
serial determinations of arterial lactate, 
pH and pCCL were carried out. The 
incision was then closed and the dogs 
were returned to the kennel. No other 
attempts were made to prolong the 
animals’ survival.
Results (Tables I to III)
Control— Group I
Immediately after a rapid infusion of 
1 1. of Ringer’s lactate solution, the 
mean arterial lactate rose from 
11.5 ±  3.01 to 22.8 ±  6.1 mg.,/100 ml. 
However, within 10 minutes, the ar­
terial lactate declined towards prein­
fusion values, and one hour after in­
fusion the arterial lactate level was at 
preinfusion values. There were no 
significant changes in arterial pH or 
pCCL values. All dogs survived 24 hours.
Control— Group II
Although these dogs received no
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TABLE I.—The Effect of R inger’s Lactate or Saline Infusion on Arterial Lactate Levels. In 
Groups II and III the T ime “ O” to “ Immediately Following Infusion”  is the Period of T otal
Hepatic Inflow Stasis
Arterial lactate 
(mg./lOO ml.)
Tim e Group I Group I I Group I I I
0 ...................................................... 11.5 ±  3.0 
22.8 ±  6.1 
16.7 ±  6.7 
9 .3  ±  2.9 
5 .7  ±  1.7
15.3 ±  11.5 
28.2 ±  13.0
32.0 ±  20.6 
31.5 ±  17
27.1 ±  19
11.1 ±  7.2 
38.4 db 8.8 
42.52 ±  8.8
32.6 ±  12.2
27.7 ±  17.6
Immediately following infusion....................
10 min. after infusion....................................
1 hr. after infusion.........................................
2 hrs. after infusion...................................
TABLE I I —The Effect of R inger’s Lactate or Saline Infusion on Arterial pH Levels. In Groups 
II and III the T ime “O” to “ Immediately Following Infusion”  is the Period of T otal Hepatic
Inflow Stasis
Tim e
Arterial p H
Group I  Group I I  Group I I I
0 ........................................................... 7.32 ±  0.06 7.35 ±  0.06 7.38 ±  0.07
7.33 ±  0.03 7.21 ±  0.C6J 7.26 ±  0.06
7.35 ±  0.04 7.21 ±  0.08 7.23 ±  0.08
7.36 ±  0.06 7.19 ±  0.10 7.25 ±  0.05 
7.35 ±  0.06 7.20 ±  0.16 7.22 ±  0 14
Immediately following infusion.....................
10 min. after infusion ...............................
1 hr. after infusion ...................................
2 hrs. after infusion .......................
TABLE III.—The Effect of Ringer’s Lactate or Saline Infusion on Arterial pC 02 Levels. In 
Groups II and III the Time “ 0 ” to “ Immediately Following Infusion”  is the Period of T otal
Hepatic Inflow Stasis
T im e
Arterial p C 0 2 changes
Group I  Group I I  Group I I I
0 ............................................ 37.0 ±  5.0 35.0 ±  5.6 33.9 db 7.5
36.7 ±  4.4 38.3 ±  9.1 34.9 ±  8.2
36.7 ±  5.7 33.6 ±  9.4 34.5 ±  12.6 f 
35.6 db 4.0 38.3 db 12.1 36.3 ±  10.1
35.8 ±  2.17 37.4 ±  12.7 42.0 d= 15.3
Immediately following infusion ............
10 min. after infusion .................................
1 hr. after infusion.........................................
2 hrs. after infusion ...........................
exogenous lactate, arterial lactate rose 
from a preinfusion mean of 15.3 ±  11.5 
to 32.0 ±  9.2 mg./lOO ml. 10 minutes 
after infusion. Over the subsequent 
monitoring period the arterial lactate 
tended to remain at this point. The 
mean arterial pH fell to 7.20 ±  0.16 
mg./lOO ml. two hours after infusion, 
but again pC02 remained relatively 
stable in each dog. Only one of the dogs 
survived 24 hours.
Experimental— Group III
Except for the immediate rise in ar­
terial lactate after infusion, the results 
in Group III are similar to those in
Group II. Two hours after infusion the 
arterial lactate in Group III was 27.7 ±  
11.0 mg./lOO ml. The mean arterial pH 
and pC02 values again remained rel­
atively stable. None of these dogs sur­
vived 24 hours.
It should be noted that one dog in 
both Groups II and III developed severe 
lacticacidemia, acidosis and terminal 
hypercarbia and died during the third 
hour after infusion.
D isc u ssio n
Under normal resting conditions the 
lactic acid-pyruvic acid ratio is ap­
proximately 10:1. Additional lactate
320 THE CANADIAN JOURNAL OF SURGERY Vol. 15
diffuses rapidly into cells and is con­
verted to pyruvic acid by lactic dehy­
drogenase (LDH). Most of the pyruvate 
is converted to glycogen but about 20% 
is oxidized in the Krebs cycle to create 
energy as well as carbon dioxide and 
water. Bicarbonate is produced from 
lactate through Krebs cycle oxidation 
and by the action of carbonic anhydrase 
on the carbon dioxide and water. The 
sodium salt of the lactate is now avail­
able to combine with the HCOs to form 
sodium bicarbonate.
Ringer’s lactate is a racemic mixture 
containing equal amounts of dextro- 
and levo-lactate of which only the levo- 
lactate is oxidizable in the Krebs cycle, 
the rest being converted to glycogen, 
freeing the sodium ion to combine with
h c o 3.13- 14
If arterial lactate levels correlate 
with survival, then in the presence of 
severe hepatic injury the addition of 
exogenous lactate may falsely raise the 
arterial lactate level and this might 
mislead the physician.
Farkouh et al.n previously demon­
strated that 60 minutes of hepatic in­
flow produced marked damage to the 
liver as determined by serum enzyme 
elevation and depression of mitochon­
drial respiration.
As can be seen from the results of the 
present experiment the dogs in Group I, 
the hepatic circulation of which was not 
disturbed, easily tolerated a lactate load 
that produced only a transient rise in 
arterial lactate and no appreciable 
change in pH or pCO=.
Control Group II, which demon­
strated the effect of 60 minutes of total 
hepatic inflow stasis on arterial lactate 
levels without an exogenous lactate load, 
points to the revascularized liver as a 
source of lactate. Group III received an 
additional exogenous load of 2520 mg. 
of sodium lactate; these dogs showed no 
significant elevation of arterial blood 
' lactate over that seen in Group II (no 
exogenous lactate).
We know little about the cause of 
death of the dogs in Groups II and III 
that did not survive 24 hours after 60
minutes of total hepatic inflow stasis. 
In both groups a progressively rising 
arterial lactate and a falling pH ap­
peared shortly before death. During the 
period of observation, one dog in both 
Groups II and III developed a progres­
sive lactic acid acidosis and hypercar- 
bia. Because there was no difference 
in the survival rate between Groups II 
and III, we did not attribute these 
deaths to the exogenous lactate load 
given to Group III.
From this experiment, there is no evi­
dence that exogenous lactate will cause 
prolonged or progressive elevation of 
arterial lactate in dogs who have a 
severe disturbance of hepatic function.
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Resume
Le but de la presente experience est d’eva- luer la possibilite, pour le chien, de supporter une forte charge exogene de lactate, en p re­sence d’une lesion hepatique severe.Les auteurs ont utilise 14 chiens batards adultes qu’ils ont repartis  en trois groupes. Le groupe I, compose de quatre chiens, a  ete m aintenu sous anesthesie pendant cinq heures. E n tre  la seconde et la troisieme heure, on leur a donne en perfusion un litre d’une solution de Ringer au lactate. Le groupe II, compose de cinq animaux, a ete soumis a une stase hepa­tique totale d ’une duree de 60 minutes et a regu durant cette periode un litre de solution physiologique saline a 0.9%. Le groupe III, comprenant cinq chiens, a  subi une stase he­patique totale pendant la meme periode mais a  regu un litre  de lactate de Ringer.Les auteurs ont mesure la teneur en lactate
du sang arteriel, le pH et la pC 02 avan t, im- m ediatem ent apres, apres 10 m inutes, une heure, et deux heures apres la stase hepatique totale. Chez le groupe I, on a note une aug­m entation brusque du lactate a rte rie l (de 11.5 ±  3.01 a 22.8 ±  6.1 mg/1'00 ml) imme- diatem ent apres la perfusion, mais cette  con­centration en lactate est revenue aux valeurs initiales une heure apres l’infusion. Chez les chiens du groupe II, le lactate a rte rie l est monte de 15.3 ± 1 1 .5  a 32.0 ±  9.2 m g/100 ml, dix minutes apres que la circulation sanguine eut ete retablie. La teneur en lac ta te  es t vir- tuellem ent demeuree a ce niveau pendant la periode de surveillance subsequente. S u r le plan statistique, il n ’y avait pas de d ifference notable dans les resu lta ts  entre le groupe II e t le groupe I I I : le lactate arteriel dans ce d er­nier groupe etait de 27.7 ±  11.0 m g/100 ml deux heures apres la perfusion et le retab lisse- m ent de la circulation sanguine dans le foie. Quant au pH et aux titre s  de pC 02, il n ’y avait guere de differences en tre  les anim aux du groupe II et du groupe III.La presente experience perm et de croire qu’une _ surcharge rapide de lactate exogene n ’en trainera pas d’augm entation prolongee ou progressive du lactate dans le sang a rte rie l de chiens souffrant d’une lesion hepatique severe.
MODERN USE OF BLOOD*
R. K. SMILEY, M.D., F .R .C .P .[C ],f Ottawa, Ont.
The purpose of this paper is to examine two aspects of blood use: (1) the discrepancy that exists between the views of individuals prominent in blood banking about how blood should be used, and the way blood is being used in cur­rent clinical practice; (2) the ultimate objectives of transfusion services and 
the implications these have for clini­cians.
The major discrepancy between au­thoritative views and our clinical prac­tice is illustrated by the statement “whole blood transfusion should be rel­egated to the limbo of the shotgun prep-
"Presented a t  the Annual Meeting of the Royal College of Physicians and Surgeons of Canada, Toronto, Ont., January  1972.
fP rofessor and Head, Departm ent of Medicine, University of O ttaw a; Head, D epartm ent of Medicine, O ttaw a General Hospital; Consul­tant, Hematology Laboratory, Ottawa General Hospital, Ottawa, Ont.
aration”.' The term “shotgun prepara­tion” has been used to describe expen­sive pharmaceutical products with mul­tiple components which may not contain sufficient amounts of a desirable com­ponent, but expose the patient to the toxicity of all components. These prepa­rations are prescribed by physicians who are unaware of the precise thera­peutic requirements of patients in the hope that some ingredient they contain will be beneficial. By drawing an anal­ogy between whole blood and “shot­gun” pharmaceutical preparations, blood bankers suggest that the prescrip­tion of whole blood is as irrational as the use of “shotgun” pharmaceutical prep­arations. There is good evidence that this viewpoint has not been adopted by clinicians. For example, one of the major reasons clinicians prescribe whole blood is to increase the oxygen-carrying capacity of a patient’s blood. Because
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the administration of concentrated red 
cells accomplishes this objective, one 
might anticipate that a major portion of 
whole blood collected by the Canadian 
Red Cross Blood Transfusion Service 
would be issued to hospitals in the form 
of concentrated red cells. In 1971, how­
ever, only 12.4% of whole blood col­
lected by the Red Cross was issued as 
concentrated red cells.2
In early 1971 the use of blood was in­
vestigated in the Department of Med­
icine of the Ottawa General Hospital, 
Ottawa, Ontario. One-third of patients 
who received red cells received them in 
the form of packed cells; the other two- 
thirds received whole blood. In both 
groups, the indication for transfusion 
was to increase oxygen-carrying capac­
ity. The reason two-thirds of these pa­
tients received whole blood was simple; 
our blood bank requisition permitted a 
physician to request whole blood or to 
specify a blood component. Our staff 
was checking the first box, which in­
dicated whole blood was required, 
rather than requesting concentrated red 
cells. An arrangement was made with 
the blood bank director that any order 
for “blood” or “ whole blood” for med­
ical patients would be filled by issuing 
concentrated red cells unless the respon­
sible physician indicated to the blood 
bank in writing or by personal contact 
that he desired whole blood. No resident 
or staff physician has made this request 
after a year; presumably the policy 
adopted has interfered in no way with 
the ability of physicians to provide op­
timal patient care. This experience sug­
gests that physicians administer whole 
blood instead of packed red cells to in­
crease oxygen-carrying capacity be­
cause they are indifferent to the advan­
tages (vide infra) of packed red cells, 
not from any conviction that whole 
blood is superior for this purpose.
The major difference between blood 
use in medical compared with surgical 
departments is that a greater number 
of surgical patients suffer from hypo­
volemic shock, in particular hemorrha­
gic shock. As I understand current sur­
gical opinion, the treatment of this 
shock has two principal objectives: to 
restore blood volume and to supply oxy­
gen-carrying capacity. Of these two ob­
jectives, the first is by far the more 
important. Clinical3 and experiment­
al4 observations in hypovolemic (hem­
orrhagic) shock suggest that the com­
bination of concentrated red cells with 
crystalloids or albumin, in appropriate 
volume, is as effective as whole blood in 
attaining these objectives. If these ob­
servations are correct, the continued 
use of whole blood in surgical depart­
ments must stem from indifference of 
surgeons to the advantages (vide infra) 
and feasibility of using packed red cells 
rather than whole blood.
During discussions of the use of red 
cells and volume agents other than plas­
ma to treat hemorrhagic shock, sur­
geons usually raise two objections. The 
first is phrased in the following way: 
“ The most physiologic substance with 
which to replace lost blood is whole 
blood.” Two of the characteristics of 
acid-citrate-dextrose (ACD) bank blood 
(Table I) suggest that the whole blood 
received by patients is unlikely to be 
physiologic. With its acid pH, elevated 
potassium and glucose content, bank 
blood resembles blood taken from a ke­
totic diabetic with renal failure. The 
second point raised by surgeons in de­
fence of whole blood is that the plasma 
provides substances necessary for he­
mostasis, e.g. platelets or coagulation 
factors. Because of the disproportionate 
requirement for red cells and substances 
necessary for hemostasis, it is more ef­
fective to provide the necessary red cells 
plus the necessary component (s) re­
quired for hemostasis. For example, we 
treat a bleeding patient with Factor 
VIII deficiency with concentrated red 
cells plus Factor VIII concentrate, 
rather than whole blood, because it is
TABLE I.— pH and Potassium Characteristics 
of Stored ACD Blood
Fresh 21 days
pH..............  7.0 6.5
Potassium. . 3-4 mEq./l. 16-17 mEq./l.
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not possible to achieve hemostatic levels 
of Factor VIII with the amount of Fac­
tor VIII contained in the whole blood 
that will provide the required red cells.
The use of concentrated red cells, 
combined with other blood components 
and crystalloids, in situations in which 
whole blood is now used has a number 
of advantages. The acid and potassium 
loads administered are less; the inci­
dence of serum hepatitis may be reduced 
and certain transfusion reactions (ur­
ticaria, fever) are less frequent and less 
severe. More important than all these 
reasons, valuable components of blood 
(platelets, albumin, Factors VIII and 
IX) can be salvaged from the plasma, 
which is given to patients who do not 
require these substances when they re­
ceive whole blood. The plasma so sal­
vaged should provide an abundant sup­
ply of these components to all hospitals 
in Canada. For example, surgical col­
leagues complain that the supply of 
serum albumin would be inadequate to 
permit its routine use with concentrated 
red cells in hemorrhagic shock. One fac­
tor limiting the supply of serum albu­
min is the relatively small volume of 
plasma available for fractionation when 
whole blood is so widely used. This 
vicious circle can be broken by the 
maximal use of packed red cells.
If packed red cells are used, is there 
any clinical situation in which we must 
insist these cells be obtained from fresh­
ly collected blood? This question arises 
because of the effect of blood storage on 
hemoglobin function. Fig. 1, from Beut- 
ler,° illustrates diagrammatically the 
“ shift to the left” that occurs in ACD 
blood during the first two weeks of 
storage. Hemoglobin in which the oxy­
gen dissociation curve has shifted to the 
left has an increased affinity for oxy­
gen, and therefore releases less oxygen 
to the tissues at any given partial pres­
sure. The clinical implications of these 
findings remain uncertain. Bunn et al.e 
state that resynthesis of the phospho- 
rylated intermediates in the red cell 
likely begins soon after infusion; the 
oxygen dissociation curve is normal in
P O  2 ( m mil g )
Fig. 1.—Schematic representation of the 
‘shift to the left” which occurs in stored ACD 
blood. (Reproduced by permission from Beutler 
E : “Shift to left” or “shift to right”  in regula­
tion of erythropoiesis (editorial). Blood  33: 
496, 1969.)
some, but not all, patients by 24 hours.7 
Further studies are needed to determine 
how quickly the defect in oxygen trans­
port is corrected in vivo. A reasonable 
interim clinical policy would be to use 
the red cells most recently collected in 
situations which require massive infu­
sions of packed red cells.
Increasing knowledge of the composi­
tion of blood, coupled with technologic 
developments, has made it possible to 
formulate the following- ultimate ob­
jectives of blood banking: (1) To sup­
ply the patient with blood components 
prepared to replace specific needs. (2) 
To supply these needs from a stockpile 
of blood components which retain their 
original properties for months or years 
—referred to subsequently as a “ stable 
source” .
The blood bank director would like 
to be in the position of a pharmacist, 
who can fill a specific prescription at 
any hour of the day or night from a 
stockpile of drugs with known biologic 
activity which does not change over 
months or years. Progress towards both 
objectives is discussed in the following 
paragraphs.
Red Cells
Red cells can be supplied as a compo-
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nent of whole blood for the specific pur­
pose of increasing the patient’s oxygen­
carrying capacity. The maximal “shelf 
life” of red cells is 21 days; if they are 
not used in this period they are dis­
carded. The 21-day limit is an arbitrary 
time adopted by blood banks because 
70% or more of the red cells in units of 
blood collected in ACD and stored under 
blood bank conditions for 21 days will 
survive normally in vivo. Red cells pre­
served in the frozen state most nearly 
meet the objective of a “stable source”. 
Different methods have been devised to 
freeze red cells and reconstitute them as 
concentrated red cells after months or 
years in storage,8 and the Canadian 
Red Cross maintains a bank of frozen 
rare bloods at the National Defence 
Medical Centre in Ottawa.9 Expense is 
the main argument against more gen­
eral use of red cells preserved in the 
frozen state. Estimated cost of a unit of 
concentrated red cells preserved in the 
frozen state is 1.5 to two times the cost 
of a similar unit of red cells which has 
not been frozen and reconstituted.10
20%
DEMAND 
SUPPLY
Fig. 2.-Diagrammatic illustration of blood 
supply and demand.
This estimate does not consider the pat­
tern of blood supply and demand in 
transfusion services, which is illus­
trated graphically in Fig. 2. During 
periods when blood supply exceeds de­
mand, up to 20% of the red cells may 
become outdated (i.e. over 21 days) be­
fore they are used. If a monetary value 
were placed on the unused red cells, and 
if it is assumed they would be salvaged 
for use through preservation by freez­
ing, the cost of a unit of red cells re­
constituted from the frozen state might 
well become competitive.
Platelets
Platelet concentrates, as a specific 
blood component, have become available
TABLE II.—Specific Plasma Components Avail­
able F rom a “Stable Source’’
Serum albumin 
Gamma globulin (IgG)
Specific hyperimmune gamma globulin 
Coagulation proteins: fibrinogen 
Factor VIII
“prothrombin complex”
from transfusion services in recent 
years. They may be concentrated from 
platelet-rich plasma stored at 22° C. for 
96 hours" and some progress has been 
made towards developing a “stable 
source” through freezing. The problems 
of platelet preservation have been re­
viewed by Gardner.12
Granulocytes
Preparation and infusion of granulo­
cytes as a specific blood component is 
feasible. Unlike red cells and platelets, 
transfusion services cannot provide 
granulocytes prepared from routine 
donor collections, and much investi­
gative work is needed before a “stable 
source” can be anticipated. A detailed 
review of usefulness, procurement and 
preservation of leukocytes has been pub­
lished.13
Plasma Fractions
The two ultimate objectives of blood 
banking—to supply specific blood com­
ponents from a “stable source”—have 
been most nearly achieved in the provi­
sion of specific plasma-protein frac­
tions. Table II lists the types of specific 
components available from a “stable 
source”.
Plasma
Whole plasma, derived from single 
donors, has a limited place in hemosta­
tic disorders, i.e. in uncommon condi­
tions for which specific components 
have not been prepared, and in more 
common disorders (e.g. Factor IX de­
ficiency) in which administration of 
available concentrates has been followed 
by a disturbing incidence of hepatitis. 
These concentrates should be avoided 
except in serious bleeding.
September 1972 MODERN USE OF BLOOD 325
S u m m a r y
Blood bankers urge clinicians to use specific blood components rather than whole blood, but extensive use of whole blood continues.
Blood component therapy has been used exclusively for one year in the De­partment of Medicine of an active teaching hospital.
The reason for failure to use blood component therapy more extensively appears to be indifference to the feas­ibility and advantages of this practice.The ultimate aims of blood banking— provision of specific blood components from a “stable source” (see text)—have been reviewed. Considerable progress has been made towards these objectives.As a result of recent progress in the development of specific blood compo­nents, clinicians should now think in terms of the patient’s specific needs and select components to supply these needs rather than attempting to meet all con­ceivable requirements with whole blood.
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R e s u m e
Une profonde divergence existe en tre  les concepts des directeurs de Banques de sang  touchant les modalites des transfusions e t la fa?on dont le sang est en fa it u tilise en p ra t i­que clinique. Les directeurs en question esti- ment que la transfusion de sang en tie r e s t une pratique desuete, qui devrait e tre  rem placee par l’adm inistration de composants specifiques du sang. Les cliniciens continuent, eux, a  re- courir sans discrimination, aux classiques transfusions de sang entier. L’au teu r a voulu comprendre pourquoi les deux tie rs  des p a ­tients hospitalises dans un service medical re- cevaient du sang entier pour re tab lir la capa­city de transpo rt d ’oxygene de leu r sang. II a ainsi decouvert que la fau te  en e ta i t  au me- decin qui negligeait de specifier une tra n s ­fusion de culot globulaire. Au cours de l’annee suivante, seuls des elements figu res  on t ete employes dans ce service e t aucun medecin n ’a reclame de sang entier. L’au teu r estim e que les services de chirurgie pourraien t u tilise r beaucoup moins de sang entier. Si cette p ra t i­que n ’a pas cours, la fau te  en rev ien t au chi- rurgien qui ne connait pas la disponibilite des elements figures et leurs avantages.Les Banques de sang se sont fixees comme objectif ultim e de garder en stock des elem ents figures specifiques qui, du reste, conservent leurs proprietes originales pendant des mois, voire des annees. Dans ce domaine, de g rands progres ont ete realises, mais ceux-ci devront encore e tre  perfectionnes av an t q u ’on puisse atte indre ces objectifs. L ’article etudie ces nou- velles acquisitions pour chaque elem ent figure. En raison des progres deja realises, les clini­ciens devraient desormais chercher a t r a i te r  les besoins specifiques de leurs m alades, p lu to t que de chercher a couvrir un peu a l’aveugle tte  tous les besoins imaginables avec du sang  en­tier.
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COMPARISON OF MEDROXYPROGESTERONE AND CORTICOSTEROIDS 
IN THE TREATMENT OF CANINE RENAL ALLOGRAFTS*
A. S. MACDONALD, M.D., F.R.C.S.[C], C. F. FALVEY, B.Sc. and 
C. C. CHAN, M.D., F.R.C.S.[C], H alifax, N.S.
T h e  immunosuppressive potency of 
medroxyprogesterone acetate (Depo- 
Provera) as measured by suppression 
of antibody production and skin allo­
graft rejection in rodents1'6 and renal 
allograft rejection in dogs5,6 parallels 
that of corticosteroids7'10 when either 
agent is used alone. The efficacy of 
corticosteroids as an adjuvant to aza- 
thioprine (Imuran) in the treatment of 
both animals and man following organ 
transplantation is well established.1118 
Several recent reports suggest that me­
droxyprogesterone may also have addi­
tive effects when used with azathio­
prine.5’ 6- 19 The present study in dogs 
receiving renal allografts was under­
taken to compare medroxyprogesterone 
and prednisone, both with respect to 
their effects when given continuously 
alone or with azathioprine, and their 
ability to reverse rejection episodes in 
azathioprine-treated animals.
M a t e r ia l s  a n d  M et h o d s
Thirty-seven pairs of unrelated mon­
grel dogs of both sexes weighing 7 kg. to 
25 kg. exchanged kidneys. The grafts 
were placed in the pelvis, and end-to- 
end renal-to-iliac arterial and end-to- 
side renal-to-iliac venous anastomoses 
and ureteroneocystotomy were per­
formed, followed by immediate excision 
of the remaining kidney. Therapy be­
gan on the day of operation and the 
recipients were allocated at random to 
one of 10 treatment groups:
Group 1.— Eight dogs received no 
drugs.
Group 2.— Seven dogs received me­
droxyprogesterone acetate3 35 mg./kg./ 
day subcutaneously.
*From the Surgical Research Laboratory, Dal- 
housie University, Halifax, N.S.
Supported by a grant from the Medical Re­
search Council of Canada.
Group 3.— Seven dogs received pred­
nisone 25 mg./kg./day orally, or methyl- 
prednisolone3 25 mg./kg./day intramus­
cularly if nauseated or vomiting.
Group -i.— Six dogs received oral 
medroxyprogesterone3 35 mg./kg./day.
Group 5.— Eight dogs received aza­
thioprine 5 mg./kg./day with the dose 
decreased or discontinued if leukopenia 
ensued.
Group 6.— Seven dogs were given 
azathioprine 5 mg./kg./day adjusting 
the dose by the leukocyte response, and 
prednisone 1.5 mg./kg./day for one 
week, tapering thereafter to 0.5 mg./ 
kg./day. If rejection developed pred­
nisone dosage was increased to 4.0 mg./ 
kg./day.
Group 7.— Eight dogs were also given 
azathioprine as above but, in this group, 
prednisone 4.0 mg./kg./day was given 
for rejection and gradually tapered and 
discontinued if the rejection episode 
subsided.
Group 8.— Eight dogs received aza­
thioprine 5 mg./kg. as above and also 
medroxyprogesterone 35 mg./kg./day 
subcutaneously continuously.
Group 9.— In seven dogs medroxypro­
gesterone 35 mg./kg./day subcutaneous­
ly was added to the azathioprine only 
for rejection and was discontinued if 
rejection subsided.
Group 10.— Eight dogs received oral 
medroxyprogesterone 35 mg./kg./day 
continuously in conjunction with the 
normal dose of azathioprine. Leuko­
penic animals in all groups were given 
either ampicillin or tetracycline 250 mg. 
twice daily by mouth or intramuscu­
larly.
All dogs had thrice-weekly hemato­
crits, white cell counts and differentials, 
and blood urea nitrogen and glucose de­
terminations. An autopsy was per­
formed on all dogs that died and their 
kidneys were examined histologically.
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TABLE I — Results in the 10 Treatment Groups
Average
survival
(days)
% survival beyond
Group treatment Survival in days Rejected 20 days 30 days 40 days
1 None 6, 7, 7, 7, 8, 10, 13, 21 9.9 8/8 12 0 0
2 Depo-Provera sub­
cutaneously 7, 8, 13, 18, 20, 27, 28 17.3 m 43 0 0
3 Prednisone or methyl- 
prednisolone
9, 10, 15, 16, 20, 24, 27 17.3 in 43 0 0
4 Provera 7, 9. 13, 14, 15, 24 13.7 6/6 17 0 0
5 Imuran 6, 8, 17, 24, 30, 43, 50. 64 30.2 6/8 63 50 38
6 Imuran +  prednisone 10, 15, 32, 39, 57, 62, 65 40.0 4/7 71 71 43
7 Imuran -f prednisone 
for rejection 13, 16, 22, 23, 32, 94 33.3 4/6 67 33 17
8 Imuran +  Depo- 
Provera 10, 20, 20, 32. 39, 51, 54, 91 39,8 2/8 88 63 38
9 Imuran +  Depo- 
Provera for re­
jection 11,31,40, 44, 46, 218*, 730* 53.0 3/7 86 86 71
10 Imuran Provera 10, 10, 12, 18, 19, 32, 37, 221* 29.7 6/8 38 38 12
*In computing average survival, long-surviving animals were credited with 100 days only.
R e s u l t s
The results are summarized in Table
I.
Group 1 (controls).— All died of ure­
mia secondary to rejection of the 
grafted kidney. Survival ranged from 
six to 21 days with an average of 9.9 
days.
Group 2 (medroxyprogesterone sub­
cutaneously only).—All dogs died of re­
jection between seven and 28 days, aver­
age 17.3 days.
Group 3 (prednisone or methylpred- 
nisolone). Rejection resulted in the 
death of all dogs between nine and 27 
days, average 17.3 days.
Group U (oral medroxyprogesterone 
only).— The six dogs died between 
seven and 24 days, average 13.7, all of 
rejection.
Group 5 (azathioprine only).— Sur­
vival averaged 30 days with a range of 
six to 64. Two of these dogs died of 
bone-marrow suppression and infection 
without uremia.
Group 6 (azathioprine and continu­
ous prednisone).— Three out of seven
dogs died of bone-marrow suppression 
and infection without uremia at 32, 39 
and 57 days. The remainder died of re­
jection between 10 and 65 days. The 
average for the seven was 40 days.
Group 7 (azathioprine and predni­
sone for rejection).— Two dogs in this 
group were excluded because they 
neither rejected the graft nor received 
prednisone. One died at 11 days of an 
intussusception and the other survived 
over a year. The remaining six dogs 
lived from 13 to 94 days, two without 
uremia, one died of bone-marrow sup­
pression and infection at 32 days, and 
the other of viral pneumonia at 94 days 
when the blood urea nitrogen (BUN) 
was 19 m g./100 ml. This dog had two 
rejection episodes reversed by predni­
sone which had been discontinued 18 
days before its death. The average sur­
vival in this group was 33.3 days.
Group 8 (azathioprine and continu­
ous medroxyprogesterone).— Average 
survival was 40 days with a range of 
10 to 91. Seven out of eight dogs sur­
vived 20 days or longer and only three 
died of uremia. One died at 20 days of
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Fig. l.-Prolonged survival of a dog treated with azathioprine in which three rejection epi­
sodes were reversed by medroxyprogesterone therapy.
renal artery thrombosis and two died 
of bone-marrow suppression and infec­
tion. One died of pneumonia with a 
chronically elevated BUN of 60 to 80 
mg./lOO ml.
Group 9 (azathioprine and medroxy­
progesterone for rejection).— Survival 
ranged from 11 days to over two years. 
If the two long-term survivors are in­
cluded as surviving only 100 days each, 
the average for this group is 53 days. 
Only one dog lived less than 30 days 
and only two died of rejection. One died 
at 31 days of bone-marrow suppression 
with a BUN of 26 mg./lOO ml., another 
at 44 days of bone-marrow suppression, 
infection and moderate uremia, and a 
third died of pneumonia at 40 days with 
a BUN of 60 mg./lOO ml. One dog died 
at 218 days of a mite infestation, with 
a BUN of 36 mg./lOO ml. This dog had 
a severe rejection at 50 days which was 
reversed by medroxyprogesterone. The 
most interesting case is a dog that is
still alive (Fig. 1). A severe rejection 
was reversed at three weeks and several 
subsequent rejections (all in the first 
year) were reversed by treatment with 
medroxyprogesterone. A rejection epi­
sode at 18 months was only partially 
reversed and at 730 days the dog is 
chronically uremic with a BUN of 70 to 
90 mg./lOO ml.
Group 10 (azathioprine and oral 
medroxyprogesterone).— One dog lived 
221 days and died of paralysis second­
ary to lumber disc extrusion. The others 
died between 10 and 37 days. If the 
long-term survivor is credited with 100 
days, the average for this group is 29.7. 
One dog died at 18 days of pneumonia 
and intraperitoneal abscess with a nor­
mal BUN. The others all rejected the 
graft.
Differential leukocyte counts re­
vealed that medroxyprogesterone- and 
prednisone-treated animals developed 
lymphopenia which was more profound
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2.—Absolute lymphocyte counts in dogs 
treated with methylprednisolone (Group 3) and 
medroxyprogesterone acetate (Group 2). The 
values are the means of the counts in those 
surviving to each time period as the numbers 
in each group progressively diminished with 
time.
and more sustained with medroxypro­
gesterone (Fig. 2).
D is c u s s io n
Survival in all the treated groups was 
better than in the controls, and the pro­
longations were statistically significant 
at the 5% level in all but the oral me­
droxyprogesterone group. The results 
in the untreated, treated with azathio- 
prine only, and azathioprine-continuous 
prednisone-treated groups are similar to 
those in earlier reports.2025 There was 
no statistically significant difference in 
average survival times in any of the aza- 
thioprine-treated groups except mar­
ginally for that group which received 
medroxyprogesterone for rejection 
crises only (P =  0.06). The results do, 
however, confirm previous reports5,6> 19 
of the efficacy of medroxyprogesterone 
combined with azathioprine in the pro­
longation of canine renal allograft sur­
vival.
In this study, as in an earlier one,19 
parenteral medroxyprogesterone ap­
pears to be as effective as, or superior 
to, prednisone as an adjuvant. Those 
animals receiving the combination of 
azathioprine and either continuous or 
intermittent medroxyprogesterone died 
not of rejection but infection, which in 
four out of these nine was associated
with severe leukopenia. Leukopenia was 
just as frequent in the other groups 
that received azathioprine but infec­
tion was a cause of death in the ab­
sence of either leukopenia or uremia in 
only the medroxyprogesterone-treated 
groups. Both prednisone and Depo-Pro- 
vera administered continuously with 
azathioprine from the day of trans­
plant seem to be effective in pre­
venting rejection during the first 20 
days. Both agents are also effective in 
reversing rejection episodes if adminis­
tered only when rejection has developed, 
which occurred in 80% of the dogs with­
in the first three weeks (Table I). Depo- 
Provera is also capable of reversing re­
jection episodes in long-surviving allo­
grafts even as late as 18 months (Fig. 
1). However, once rejection became evi­
dent in the azathioprine-only treated 
group, reversal did not occur, either 
spontaneously or in response to in­
creased dosage of azathioprine.
In this study the results with medro­
xyprogesterone are not as good as those 
reported by Turcotte et al.s■6 They dis­
continued azathioprine at 60 days and 
reduced the Depo-Frovera to two injec­
tions per week. Some deaths from infec­
tion and leukopenia could perhaps have 
been avoided in our longer survivors if 
we had done the same.
Unfortunately, medroxyprogesterone 
is poorly absorbed from the gastroin­
testinal tract, which probably explains 
the inferior results in the group treated 
with the oral form. Medroxyproges­
terone can be detected in the serum of 
dogs as long as 90 days after a single 
intramuscular injection. Absorption is 
not only prolonged but often incomplete 
and granuloma formation at the site of 
injection was frequent in our dogs al­
though ulceration or sinus formation 
did not occur. Like corticosteroids, 
medroxyprogesterone causes lympho­
penia20 which is more profound and 
more sustained with the latter drug 
(Fig. 1). It is also catabolic27 causing 
weight loss in all the dogs receiving it 
in this study, and even more so in rab­
bits. When combined with prednisone,
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the weight loss in rabbits is catas­
trophic (unpublished observations). It 
is reported to decrease granuloma for­
mation in rats28 and we have found that 
it delays wound healing in both rats and 
rabbits (Lenco and Macdonald, unpub­
lished).
In croton-oil granuloma pouches, its 
anti-inflammatory effects appear to be 
equal on a weight basis to those of 
hydrocortisone28 with less catabolic and 
glycogenic activity.27 The drug acts on 
the pituitary to suppress ACTH and 
gonadotrophic hormone production (but 
not thyrotrophic or growth-hormone re­
lease). Adrenal atrophy occurs in expe­
rimental animals but adrenal response 
to ACTH is prompt and vigorous26 and 
withdrawal of the drug is not followed 
by symptoms of adrenal insufficiency. 
Camanni, Massara and Molinatti29 re­
ported that medroxyprogesterone ace­
tate supported life and reversed symp­
toms of adrenal insufficiency in five 
adrenalectomized women. It was not ef­
fective in two ovariadrenalectomized 
women. Despite extensive clinical use 
of this agent over the past 10 years, 
there are no reports of Cushing’s syn­
drome or adrenal insufficiency second­
ary to its use in humans even with the 
massive doses used in the treatment of 
uterine cancer. Medroxyprogesterone 
appears to share the beneficial anti­
inflammatory effects of the corticoste­
roids without many of the deleterious 
side effects.
Survival of renal allografts in dogs 
is still measured in days5’ 6' 10’ n’ I5'17' sws 
rather than in the months and years 
that identical agents achieve in human 
kidney transplants. With some justifica­
tion it is assumed that any agent suc­
cessful in the dog is likely to be even 
more effective in man. The results of 
this study suggest that medroxyproges­
terone may be useful in clinical trans­
plantation. The drug would be of par­
ticular value where pregnancy is con­
traindicated in female transplant reci­
pients, and the immunosuppressive and 
contraceptive properties of this agent 
would be combined.
S u m m a r y
Seventy-two dogs receiving renal al­
lografts were divided into 10 treatment 
groups. The therapy and the average 
survival time for each group were as 
follows: (1) controls, 9.9 days; (2) pa­
renteral medroxyprogesterone acetate 
(Depo-Provera), 17.3 days; (3) predni­
sone or methylprednisolone (Solu- 
Medrol), 17.3 days; (4) oral medro­
xyprogesterone (Provera), 13.7 days;
(5) azathioprine (Imuran), 30.2 days;
(6) azathioprine plus continuous pred­
nisone, 40 days; (7) azathioprine plus 
prednisone for rejection, 33.3 days; (8) 
azathioprine plus continuous parenteral 
medroxyprogesterone, 39.8 days; (9) 
azathioprine plus parenteral medroxy­
progesterone for rejection, 53.0 days; 
(10) azathioprine plus continuous oral 
medroxyprogesterone, 29.7 days. It is 
concluded that medroxyprogesterone 
acetate is as effective as prednisone in 
prolonging kidney graft survival and 
reversing graft rejection. The two ste­
roids appear to have a similar mode of 
action, but medroxyprogesterone does 
not have many of the deleterious side 
effects of corticosteroids.
Medroxyprogesterone was supplied as 100- 
mg. oral tablets (Provera) and as 400-mg./c.c. 
injectable (Depo-Provera), and methylpredni­
solone injectable 40 mg./c.c. and 67.5 mg./c.c. 
(Solu-Medrol) through the courtesy of the Up­
john Co., Toronto, Ont. and Kalamazoo, Mich.
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R e s u m  &
Nous avons reparti en 10 groupes 72 chiens 
chez lesquels on avait pratique des hetero- 
grefies renales. Le traitement et la peniode 
moyenne de survie se presentaient comme suit: 
(1) temoins— 9.9 jours; (2) acetate de me­
droxyprogesterone parenteral (Depo-Provera)
, (3) prednisone ou methylpredni-
solone (Solu-Medrol)— 17.3 jours; (4) medro­
xyprogesterone orale (Provera)— 13.7 jours- 
(5) azathioprine (Imuran)—30.2 jours- (6) 
azathioprine plus prednisone continue—40 
jours, ( / )  azathioprine plus prednisone pour 
le rejet 33.3 jours; (8) azathioprine plus 
medroxyprogesterone parenterale continue— 
39.8 ours; (9) azathioprine plus medroxypro­
gesterone parenterale pour le rejet__53.0
jours; (10) azathioprine plus medroxyproges­
terone orale continue—29.7 jours. Les auteurs 
concluent que 1’acetate de medroxyprogesterone 
est aussi efficace que la prednisone pour 
prolonger la survie du rein greffe et empecher 
la reaction de rejet. Les deux stero'ides ont un 
mode d action similaire, mais la medroxypro­
gesterone n’a pas autant de reactions secon- 
daires defavorables que les corticoi'des.
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B O O K  R E V I E W S
ARTIFICIAL ORGANS AND CARDIO­
PULMONARY SUPPORT SYSTEMS. 
Edited by Felix T. Rapaport and John 
P. Merrill. 186 pp. Illust. Grune & Strat­
ton, Inc., New York; Longman Canada 
Limited, Toronto, 1971. $17.25.
This monograph comprises the papers 
presented at a symposium held at New 
York University in September 1971. In the 
first paper, Scribner describes his life 
plan concept and emerging interrelation­
ship between kidney transplantation and 
regular dialysis. Based on his extensive 
experience, he describes his plans for the 
management of end-stage kidney disease 
for long-term active survival. Discussions 
of the engineering aspects of artificial 
kidneys and of biological considerations 
complete the chapter. The next chapter, 
“Cardiopulmonary Support Systems” , con­
tains reviews of the current status of the 
artificial lung and extracorporeal respir­
atory support with auxiliary lungs, and 
also considers medical as well as engin­
eering aspects. Hill presents clinical ex­
perience with prolonged extracorporeal 
circulation for respiratory insufficiency. 
The artificial heart is discussed by De- 
Bakey and by Kolff. Several contributions 
are devoted to assisted circulation with 
and without auxiliary lung, including the 
bloodless method of external pressure ap­
plication. One of the main problems in all 
systems is thrombosis, which is ably dis­
cussed by Salzman. The third chapter, 
“Alimentary and Metabolic Life Support 
Techniques” , starts with a description of 
long-term parenteral alimentary support 
by Rhodes, followed by several contribu­
tions on the treatment of liver failure. Fi­
nally, the questions of artificial skin and of 
organ preservation are discussed briefly. 
The monograph is an excellent review of 
the current state in the U.S.A. of the pro­
vision of artificial organs and of related 
topics. It is useful for investigators active 
in some of the fields covered in the book. 
It can also be considered as an introduc­
tion to the field of artificial organs for 
medical doctors, engineers and others 
interested in these developments. It should 
be read by medical students, interns and 
residents who require some knowledge of 
artificial organs and the implications of 
their use, subjects that tend to be in­
adequately covered in their textbooks.
W . ZlNGG
The Hospital for Sick Children,
Toronto, Ont.
DIE FETTEMBOLIE. Gyorgy Szabo 284
pp. Illust. Akademiai Kiado, Budapest,
1971. $10.00.
This extensive monograph, written by a 
staff surgeon of the Central Institute for 
Traumatology in Budapest, discusses fat 
embolism in all its aspects. In a series of 
logically organized chapters he analyzes 
in fine detail the various problems 
presented by the condition. His conclu­
sions are based on his extensive personal 
experience (200 cases). The book is com­
pleted by a series of references in the 
medical literature dating from 1669 to the 
present.
The discussion in the final chapter of 
the causes of death in fatal cases of fat 
embolism is of great medicolegal impor­
tance and deserves the careful attention of 
all doctors working in general and ortho­
pedic surgery.
L. G. Farkas
The Hospital for Sick Children,
Toronto, Ont.
GASTROESOPHAGEAL REFLUX AND 
HIATAL HERNIA. Edited by David B. 
Skinner, Ronald H. R. Belsey, Thomas 
R. Hendrix and George D. Zuidema. 208 
pp. Illust. Little, Brown and Company 
(Inc.), Boston; J. B. Lippincott Com­
pany of Canada Ltd., Toronto, 1972. 
$13.50.
The authors of this text are experienced 
and well known in the field of esophageal 
studies. They have combined their talents 
to produce a book which clearly is the best 
available text on the subject of hiatal 
hernias. They have extensively reviewed 
the literature and have described well 
the anatomy, physiology and pathology 
of hiatal hernias. Using this basic knowl­
edge they have outlined their approach to 
the investigation and management of eso­
phageal disease.
The authors describe the various ap­
proaches to surgical management with 
emphasis on the procedures that they have 
been responsible for pioneering. Their 
own extensive experience is reviewed to 
illustrate the problem areas of esophageal 
surgery.
The discussion of alternative surgical 
management, particularly in the area of
(Continued on Adv. p. 30)
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peptic stricture, is brief, and these 
techniques are too readily dismissed as 
being of little value.
The book is easy to read, well illustrated 
and contains most of the references rele­
vant to the work described. Anyone in­
terested in the field of esophageal surgery 
will find the book provocative and prof­
itable.
R. D. H enderson
Toronto General Hospital,
Toronto, Ont.
MODERN TRENDS IN ORTHOPAEDICS 
— 6. Edited by A. Graham Apley. 273 pp. 
Illust. Butterworth & Co. (Publishers) 
Ltd., London; Butterworth & Co. (Can­
ada) Ltd., Toronto, 1972. $28.90.
This volume makes no claim to be ex­
haustive or comprehensive but devotes at­
tention to a number of topics that are of 
current interest to orthopedic surgeons 
and therefore reflects present-day prac­
tice. It should be of particular value to 
residents in training and should be placed 
in the library of every teaching orthopedic 
department. From time to time throughout 
the book an unusual slant on a common 
topic is encountered; for example, the ref­
erence to manipulation in the chapter on 
epidurography and the discussion of the 
“ ideal hip” in the chapter on total hip 
replacement. In this way some excitement 
is provided. The book is clearly written 
and the illustrations, which are numerous, 
are all of excellent quality.
W . H. K irkaldy-W illis
University Hospital,
University of Saskatchewan,
Saskatoon, Sask.
ORTHOPAEDIC SURGERY IN SPASTIC­
ITY. Harold M. Frost. Orthopaedic 
Lectures, Volume I. 216 pp. Illust. Char­
les C Thomas, Publisher, Springfield, 
111.; McGraw-Hill Company of Canada, 
Toronto, 1972. $15.20.
The natural history of orthopedic surgery 
in spastic disorders is all too often a 
relentless progression from proselytizing 
enthusiasm in the young staff surgeon to 
cynical skepticism in his more senior 
colleagues. Dr. Frost has obviously 
laboured long and conscientiously in the
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field but has resolved to eschew negativ­
ism in favour of struggling to separate the 
wheat from the chaff and, what is more 
important, to attempt a logical decision 
as to whether to thresh at all.
The first section of the monograph at­
tempts to explain why the locomotor sys­
tem of the spastic is unique. It is em­
phasized that the laboriously acquired 
knowledge and techniques applicable to 
the handling of post-poliomyelitic motor 
defects have relatively little to offer 
in the problems of the spastic. Dr. Frost’s 
concepts are based on practical experience 
and personally evolved rules that work 
for him—and as such are untested by 
neuroanatomical or neuropathologic in­
vestigation.
The author then discusses specific com­
mon problems and his own techniques for 
management. Of particular value is the 
endeavour to explain why the success of 
one technique could be anticipated; op­
tional techniques are carefully assessed 
rather than curtly discarded.
While of undeniable interest and value 
to orthopedic surgeons at all levels of ex­
perience, this book does not make for easy 
reading. It does, none the less, contain a 
great deal of information (often in what 
are almost side comments) on the value 
of non-surgical measures, including 
bracing. Particularly, there is an under­
lying philosophy of encouragement for all 
those involved in the overall management 
of the still baffling and perplexing peri­
pheral manifestations of central neurol­
ogic disease.
In summary this book is a useful contri­
bution to the literature concerning ortho­
pedic surgery in cerebral palsy.
W. J. S. Melvin
Scarborough General Hospital, 
Scarborough, Ont.
ORTHOPAEDICS IN INFANCY AND  
CHILDHOOD. G. C. Lloyd-Roberts. 
Postgraduate Paediatrics Series. General 
Editor: John Apley. 337 pp. Must. 
Butterworth & Co. (Canada) Ltd., To­
ronto; Butterworth &  Co. (Publishers) 
Ltd., London, 1971. $26.00.
Although orthopedic surgeons have accu­
mulated a vast amount of clinical experi­
ence in the problems of pediatric patients, 
relatively few texts in children’s ortho­
pedics are available. The deficiency is suc­
cessfully alleviated by this comprehensive 
text.
(Continued on Adv. p. 39)
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The volume p resen ts  the  clin ical ex­
periences and philosophies of its  au th o r, 
an em inent B ritish  orthopedic su rgeon  on 
the  s ta f f  of the H ospita l fo r  Sick C hildren , 
G reat Ormond S tree t, London. He deals 
w ith  p a rtic u la r  problem s accord ing  to the  
diseases responsible and the anatom ical 
a reas  involved.
The tex t would have benefited  from  
con tribu tions by o ther em inent o rth o ­
pedic surgeons w ith  expertise in th e  sub ­
jec ts  included in the  chap ters on m eta­
bolic diseases, m iscellaneous conditions, 
the shoulder and elbow, and the  fo rearm  
and  hand. C hap ters th a t  deserve o u ts ta n d ­
ing p ra ise  are  those devoted to in fec tions 
of bones and jo in ts , d iso rders of th e  cen­
tra l  nervous system , the  spine and  tru n k , 
the hip and th igh , th e  foot, and th e  section 
en titled  “General T opics” .
The book was m eant to be a guide fo r 
p ed ia tric ians and a usefu l m anual fo r 
orthopedic surgeons and succeeds su p e rb ­
ly. I t  is recom m ended fo r general p ra c ti­
tioners, medical s tuden ts, and in te rn s  and 
residen ts in both ped ia trics and  o rth o ­
pedic surgery .
The illu stra tio n s, a lthough re la tiv e ly  
few in num ber, a re  of excellent quality .
The b ib liography  w ill, in  m ost in stan ces , 
be o f g rea t benefit to  those in te re s te d  in 
fu r th e r  read ing  ab o u t any  specific  su b ­
ject.
T h is te x t can  be re a d  w ith  en joym en t as 
w ell as p ro fit and w ill be of th e  g re a te s t  
service to a ll w ith an  in te re s t in  o rth o ­
pedic problem s in ch ild ren .
R . A .  S i l v e r
U.S. Public H ealth  S erv ice H ospita l, 
S eattle , W ash.
SURGICAL DISORDERS OF THE PERI­
PHERAL NERVES. Herbert Seddon. 
332 pp. Illust. Churchill Livingstone, 
Edinburgh and London; Longman Can­
ada Limited, Toronto, 1972. $29.00.
S ir H e rb e rt Seddon w as one of the  m em ­
bers of the  P e rip h e ra l N erve C om m ittee 
of th e  M edical R esea rch  Council o f E n ­
g land  responsible fo r  policies to  im prove 
th e  m anagem ent o f nerve  in ju rie s  d u rin g  
W orld W ar II. I t is a delight, th e re fo re , 
to have available th e  ex tensive experience  
of th is  surgeon in a form  fo r  s tu d y  by 
those of us also en g ag ed  in th is  problem , 
and fo r th e  young m en of the  fu tu re . A 
b r ie f  exposition o f o u r  p resen t know ledge
(Continued on Adv. p. 41)
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reg a rd in g  gross and u ltra s tru c tu re  of the 
nerves is followed by a s ta tem en t of 
p resen t th ink ing  on the  problem s of 
degeneration  and  regeneration . The au ­
th o r outlines the  g enera l c lin ica l ex­
am ination  in detail. He describes the 
p rogress during  recovery  and the  use of 
e lec trical investigation  in d iagnosis and 
prognosis. The m echanism s of in ju ry  are  
d iscussed, w ith  tab les show ing the  re la tiv e  
involvem ents of ind iv idual nerves as well 
as the  - likely dam age to  o ther tis su e s  in 
th e ir  v icinity . The p a in fu l conditions a s ­
sociated  w ith p erip h era l nerve in ju rie s  
a re  well discussed, p a r tic u la rly  the  d is­
tinc tion  betw een tru e  causalg ia  and  the 
o ther more common p a in fu l syndrom es. 
A fte r  the descrip tion  of general problem s, 
the nerves are  considered ind iv idually  in 
considerab le detail. The section on t r e a t ­
m ent deals no t only w ith  operative pro­
cedures but also w ith p reopera tive  m an­
agem ent and the tre a tm e n t of res id u a l 
fu n c tiona l d isab ilities. The a u th o r’s re ­
su lts  receive detailed analysis an d  the 
book is com pleted w ith a considerab le  lis t 
of references.
This book should be in  the lib ra ry  of 
the  surgeon  dealing w ith  p e riphera l nerve
d iso rders and  should  fo rm  p a r t  o f th e  re ­
qu ired  read in g  fo r  re s id e n ts  in t r a in in g  in 
neu rosu rgery , o rth o p ed ic  su rg e ry  and  
p lastic  surgery .
K .  W .  E .  P a i n e
U niversity  H ospital,
U niversity  of S askatchew an ,
Saskatoon, Sask.
TRANSPLANTATION REVIEWS. 7. Im­
munological Surveillance Against Neo­
plasia. Edited by Goran Moller. 178 pp. 
Illust. Munksgaard, Copenhagen, 1971. 
Dan. Kr. 92,00. $13.25 (approx.). Paper- 
bound.
“Im m unological S u rve illance  in N eo­
p la s ia”, num ber 7 in a series e n title d  
“T ran sp lan ta tio n  R eview s”, is in tro ­
duced ap p ro p ria te ly  by S ir M acF arlan e  
B urnet. I t  is now g en e ra lly  ag reed  th a t  
most, b u t not n ecessa rily  all, m a lig n a n t 
cells have an tigen ic  q u a litie s  d is tin c t 
from  those of th e  cell type from  w hich  
they  are  derived. F u rth e rm o re , such  a n ti­
genic d ifferences can, u n d er a p p ro p ria te  
conditions, be recognized  as fo re ig n  and  
(Continued on Adv. p. 43)
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INSTRU CTIO NS TO CONTRIBUTORS Vol. 154.2
THE CANADIAN JOURNAL OF SURGERY
All communications concerning this journal 
should be marked “The Canadian Journal of 
Surgery” and addressed to the Editor, P.O. 
Box 8650, Ottawa, Ontario K1G 0G8.
The Journal is published bi-monthly. Sub­
scription is $15 per year ($7.50 per year for 
trainees in surgery) and starts with the Janu­
ary issue of each year. Single copies are $2.50 
each, payable in advance.
INSTRUCTIONS TO CONTRIBUTORS 
Manuscripts
Manuscripts in duplicate of original articles, 
case reports, and other contributions should 
be forwarded with a covering letter re­
questing consideration for publication in 
The Canadian Journal of Surgery. Accept­
ance is subject to the understanding that 
they are submitted solely to this Journal, 
and will not be reprinted without the con­
sent of the author and the publishers. Ac­
ceptance or rejection of contributors will be 
determined by the Editorial Board. As 
space is available, a limited number of case 
reports will be published. Articles should 
be typed on one side only of unruled paper, 
double-spaced, and with wide margins. The 
author should always retain a carbon copy 
of material submitted. Every article should 
contain a summary of the contents. The 
Concise Oxford Dictionary will be followed 
for spelling. Dorland’s Illustrated Medical 
Dictionary will be followed for scientific 
terminology. The Editorial Board reserves 
the right to make the usual editorial changes 
in manuscripts, including such changes as 
are necessary to ensure correctness of gram­
mar and spelling, clarification of obscurities 
or conformity with the style of The Cana­
dian Journal of Surgery. In no case will 
major changes be made without prior con­
sultation with the author. Authors will 
receive galley proofs of articles before pub­
lication, and are asked to confine altera­
tions of such proofs to a minimum.
Reprints
Reprints may be ordered on a form which 
will be supplied with galley proofs. It is 
important to order these before publication 
of the article, otherwise an extra charge 
for additional type-setting will be made.
References
References should be referred to by numer­
als in the text. They should include in 
order: the author’s name and initials in capi­
tals, title of the article, abbreviated journal 
name, volume number, page number and 
year. The abbreviations of journal names 
should be those used in Index Medicus. 
References to books should include in order: 
author’s name and initials, title of book, 
number of edition (e.g. second ed.), city 
of publication, title of publishing house, 
year of publication, page number if a 
specific reference. For examples, see this 
journal January 1971 issue onwards.
Illustrations
A reasonable number of black-and-white 
illustrations will be reproduced free with 
the articles. Colour work can be published 
only at the author’s expense. Photographs 
should be glossy prints, unmounted and 
untrimmed, preferably not larger than 8" 
x 6". Prints of radiographs are required 
and not the originals. The magnification of 
photomicrographs must always be given. 
Photographs must not be written on or 
typed on. An identifying legend may be 
attached to the back. Patients must not be 
recognizable in illustrations, unless the 
written consent of the subject for publica­
tion has been obtained. Graphs and dia­
grams should be drawn in India ink on 
suitable white paper. Lettering should be 
sufficiently large that after reduction to 
fit the size of the Journal page it can still 
be read. Legends to all illustrations should 
be typed separately from the text and sub­
mitted on a separate sheet of paper. Illustra­
tions should not be rolled or folded.
Language
It should be clearly understood that con­
tributors are at full liberty to submit articles 
in either English or French, as they please. 
Acceptance will be quite independent of 
the language of submission. If the contri­
butor wishes, he may submit an informative 
summary of not more than 300 words in 
the language other than that in which he has 
submitted the article. For example, an ar­
ticle in English must carry an English sum­
mary and may, if the author wishes, carry 
a more detailed summary in French.
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produce an immune response, based on 
thymus-dependent immunocytes, equiv­
alent to homograft rejection.
In this monograph, Prehn and Lappe 
support the concept that although specific 
immune reactivity may sometimes be ade­
quate to control a neoplasm, lesser degrees 
of immune reactivity may actually promote 
growth of nascent tumours.
Possibilities for immunotherapy, the 
present status of carcinoembryonic anti­
gens, the relationship between suscepti­
bility to the development of reticuloendo­
thelial malignancy and HL-A typing, and 
the increased incidence of malignant tu­
mours in patients after organ transplan­
tation have been reviewed in interesting 
detail.
This review is recommended to anyone 
who wishes a concise summary of the con­
cept of immunologic surveillance against 
cancer.
L .  D. M a c l e a n
Royal Victoria Hospital,
Montreal, Que.
TRANSPLANTATION R E V IE W S .  8. 
Immunological Tolerance. Effect of An­
tigen on Different Cell Populations. 
Edited by Goran Moller. 136 pp. Illust. 
Munksgaard, Copenhagen, 1972. Dan. Kr. 
74,75. $10.75 (approx.). Paperbound.
This text is number 8 in a series entitled 
“Transplantation Reviews” and consists 
of five comprehensive articles written 
by authorities on various aspects of im­
munologic tolerance. This publication will 
be of greatest interest to immunologists 
active in research, and to surgeons in the 
field of transplantation. The monograph 
is mainly concerned with cellular events 
leading to a state of immunologic un­
responsiveness or tolerance, with the 
characteristics of this state and the 
cellular changes that occur when the 
tolerant state terminates.
L .  D .  M a c l e a n
Royal Victoria Hospital,
Montreal, Que.
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LE JOURNAL CANADIEN DE CHIRURGIE
Toute communication concernant le Journal 
devra porter la mention “Le journal canadien 
de chirurgie” et etre adressee a l’Editeur, P.O. 
Box 8650, Ottawa, Ontario K1G 0G8.
Le journal est publie a tous les deux mois. 
Le prix de l’abonnement est de $15. par an 
($7.50 par an pour les medecins qui sont resi­
dents en chirurgie) et commence avec le nu­
mero de janvier de chaque annee. Un exem- 
plaire isole coute $2.50 et est payable d’avance.
INSTRUCTIONS A NOS 
COLLABORATEURS
Manuscrits
Les manuscrits d’articles originaux, de rap­
ports cliniques etc. seront envoyes en deux 
exemplaires, accompagnes d’une lettre deman­
dant qu’on veuille bien considerer leur publica­
tion dans L e journal canadien de chirurgie. Ils 
ne seront acceptes qu’a la condition qu’ils 
n’aient ete soumis qu’a notre Journal et qu’ils 
ne soient pas reimprimes sans le consentement 
expres de l’editeur et l’auteur. L’acceptation 
ou le refus des articles soumis releve du Con- 
seil de la publication. Si la place est disponible, 
un nombre limite d’histoires cliniques pourront 
etre publiees. Les articles seront dactylographies 
sur un seul c6te d’un papier non ligne, a dou­
ble espace et avec une large marge. L ’auteur 
devra toujours conserver une copie au papier 
carbone du texte soumis. Tout article devra 
etre accompagne d’un resume. L ’orthographe 
sera celle adoptee par le dictionnaire Larousse. 
Quant a la terminologie scientifique, elle sera 
basee sur le Dictionnaire des termes techniques 
de medecine ou tout autre ouvrage de refe­
rence serieux. Le Conseil de la publication se 
reserve le droit d’apporter au texte les change- 
ments qu’il jugerait a propos pour assurer la 
correction grammaticale et l’orthographe, pour 
eliminer d’eventuelles obscurites ou pour ren- 
dre la presentation conforme au style du Jour­
nal canadien d e chirurgie. Aucun changement 
important ne sera apporte au texte sans que 
l’auteur ait ete prealablement consulte. Les 
auteurs recevront avant la publication des 
epreuves d’imprimerie de leur texte, auxquelles 
ils sont pries d’apporter le minimum de correc­
tions.
Tires-d-part
On pourra commander des tires-a-part sur 
une formule qui est envoyee avec les epreuves. 
11 est important de les commander avant la 
publication de l’article, sous peine de devoir 
payer un supplement pour une nouvelle com­
position.
Bibliographie
Les references bibliographiques seront indi- 
quees par des numeros dans le corps du texte. 
Elies comprendront dans l’ordre: le nom de 
hauteur et ses initiales, en majuscules, le titre 
abrege du Journal, le numero du volume, le 
numero de la page et l’annee. Les abreviations 
admises pour les noms de revues sont celles qui 
figurent dans I’index Medicus. Les renvois aux 
livres comprendront dans l’ordre: le nom de 
l’auteur, ses initiales, le titre de l’ouvrage, le 
numero de l’edition (p. ex. deuxieme ed.), la 
ville et le nom de la maison d’edition, et 
l’annee de la publication; enfin, le numero de 
la page s’il s’agit d’un renvoi precis. Pour 
exemples, voyez Tissue de janvier 1971 et ceux 
a venir.
Illustrations
Le journal accepte de publier gratuitement 
un nombre raisonnable d’illustrations en noir 
et blanc. Les reproductions de cliches en cou- 
leurs seront publies aux frais de l’auteur. Les 
photographies seront imprimees sur papier bril- 
lant, ne seront ni montees ni calibrees et d’un 
format maximum de 6" x 8". En ce qui con- 
cerne les radiographies, nous demandons des 
copies et non pas Voriginal. On devra toujours 
fournir un agrandissement de microphotogra­
phies. II ne faut jamais ecrire ou dactylogra- 
phier un texte quelconque sur les photogra­
phies. Une legende les identifiant pourra etre 
jointe au dos. Dans les illustrations montrant 
des malades, ceux-ci ne pourront etre reconnus, 
a moins qu’ils n’en aient donne le consentement 
ecrit prealablement a la publication. Les gra- 
phiques et diagrammes seront dessines a l’en- 
cre de Chine sur un bon papier a dessin blanc. 
Le lettrage devra etre ecrit en caracteres assez 
grands pour que, apres reduction proportion- 
nelle au format du Journal, ils soient encore 
lisiblesv Les legendes devant accompagner les 
illustrations seront dactylographiees sur une 
feuille independante du texte. Les illustrations 
ne seront ni roulees ni pliees.
Langue vehiculaire
II doit etre clairement etabli que les colla- 
borateurs ont pleine liberte de soumettre leurs 
articles en frangais ou en anglais, a leur choix. 
L ’acceptation de l’article sera entierement inde­
pendante de la langue choisie par l’auteur. Si 
le collaborateur le desire, il peut decrire le 
contenu de l’article en un sommaire ne depas- 
sant pas 300 mots et dans une langue differente 
de la langue choisie pour 1’article lui-meme. 
Par exemple, un article ecrit en framjais doit 
comporter un resume en franjais et peut, si 
l’auteur le desire, etre accompagne d’un som­
maire plus detaille en anglais.
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Aktuelle Orthopadie. Heft 4. Edited by Horst 
Cotta. Die Begutachtung von Schleuder- und 
Abknickverletzungen der Halswirbelsaule. 
Peter Hinz and Rochus Plaue. Moglichkeiten 
und Grenzen der Skelett-Szintigraphie fur 
die Orthopadie. Jurgen Dreyer and Peter 
Georgi. 60 pp. Illust. Intercontinental 
Medical Book Corp., New York; Georg 
Thieme Verlag, Stuttgart, 1972. DM 39,80. 
$11.65 (approx.). Paperbound.
Anaesthesia in Organ Transplantation. Edited 
by H. Hilary Howells and Alan W. Grogono. 
170 pp. Illust. S. Karger, Basel; Intercon­
tinental Medical Book Corp., New York, 
1972. $22.50.
Angiographie und Ihre Fortschritte. Arbeits- 
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Paperbound.
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H. Egdahl, John A. Mannick and Lester F. 
Williams, Jr., 484 pp. Grune & Stratton, Inc., 
New York, 1972. $13.50. ($8.75 Paper-
bound.)
Embryology for Surgeons. The Embryological 
Basis for the Treatment of Congenital De­
fects. Stephen Wood Gray and John Elias 
Skandalakis. 918 pp. Illust. W. B. Saunders 
Company, Philadelphia; W. B. Saunders 
Company Canada Limited, Toronto, 1972. 
$37.10.
Hemobilia. (Biliary Tract Hemorrhage). His­
tory, Pathology, Diagnosis, Treatment. Phi­
lip Sandblom. 146 pp. Illust. Charles C 
Thomas, Publisher, Springfield, 111.; Mc­
Graw-Hill Ryerson Limited, Toronto, 1972 
$19.75.
The Human Spine in Health and Disease.
Georg Schmorl and Herbert Junghanns. 2nd 
American edition translated and edited by 
E. F. Besemann. 504 pp. Illust. Grune & 
Stratton, Inc., New York; Longman Can- 
ada Limited, Toronto, 1971. $43.70.
Intravenous Hyperalimentation. Edited by 
George S. M. Cowan, Jr. and Walter L. 
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ladelphia; The Macmillan Company o f Ca­
nada Limited, Toronto, 1972. $13.25.
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diagnose. Hans-Klaus Zinser. 134 pp. Illust. 
Intercontinental Medical Book Corp., New 
York; Georg Thieme Verlag, Stuttgart, 1972. 
DM 29,70. $8.70 (approx.). Paperbound.
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Edited by Robert E. Condon and Lloyd M. 
Nyhus. 385 pp. Illust. Little, Brown and 
Company, Boston; J. B. Lippincott Company 
of Canada Ltd., Toronto, 1972. $7.95. Paper- 
bound.
Orthopaedic Surgery in Spasticity. Harold M. 
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pp. Illust. Charles C Thomas, Publisher, 
Springfield, 111.; McGraw-Hill Company of 
Canada, Toronto, 1972. $15.50.
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6th ed. John Crawford Adams. 312 pp. Illust. 
Churchill Livingstone, Edinburgh; Longman 
Canada Limited, Toronto, 1972. $8.00.
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and Neck. Proceedings of the First Inter­
national Symposium. Edited by John Conley 
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tative Surgery. 368 pp. Illust. Georg Thieme 
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mation. J. J. Longacre. 170 pp. Illust. Charles 
C Thomas, Publisher, Springfield, 111.; 
McGraw-Hill Ryerson Limited, Toronto, 
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Smith. 340 pp. Illust. W. B. Saunders Com­
pany, Philadelphia; W. B. Saunders Com­
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by Hans Balner and Jon J. van Rood. 152 
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